1
|
Wang Y, Zhao H, Tian L, Huang YB, Wu JJ, Wang J. [Comparison of efficacy between short-term personalized vestibular rehabilitation supervised by special personnel and fixed vestibular rehabilitation on recurrent peripheral vertigo]. Zhonghua Yi Xue Za Zhi 2024; 104:1132-1137. [PMID: 38583042 DOI: 10.3760/cma.j.cn112137-20231213-01376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/08/2024]
Abstract
Objective: To explore the efficacy of short-term personalized vestibular rehabilitation supervised by special personnel (ST-PVR) versus fixed vestibular rehabilitation (FVR) on decompensated recurrent peripheral vertigo. Methods: A randomized controlled trial was carried out. Patients diagnosed with decompensated recurrent vertigo in the clinic of Eye & ENT Hospital, Fudan University from January to December 2018 were randomly allocated into FVR and ST-PVR groups via computer-generated randomization. The FVR group received fixed scheme involving gaze stabilization exercises, habituation exercises, balance and gait training, while the ST-PVR group received individualized training programs based on symptoms and vestibular function examination results, with adjustments made according to the progress of recovery. Patient symptoms and vestibular function improvement were assessed using the dizziness handicap inventory (DHI), activities-specific balance confidence (ABC), self-rating anxiety scale (SAS), caloric test, and sensory organization test (SOT) at 2, 4, and 8 weeks of treatment. Results: A total of 44 patients were included, including 16 males and 28 females, with an average age of (50.6±13.5) years. There were 21 cases in the FVR group and 23 cases in the ST-PVR group. In the ST-PVR group, DHI score (49.5±26.8 vs 61.3±21.4, P=0.046) and SAS score (39.1±7.8 vs 44.3±6.6, P=0.021) significantly improved after 2 weeks of treatment, while significant improvement occurred only after 8 weeks of treatment in the FVR group (DHI score: 28.1±15.9 vs 53.1±18.5, P=0.001; SAS score: 35.3±6.7 vs 43.1±8.4, P=0.010). There was no significant change of ABC score in the FVR group after 8 weeks of treatment (86.5±12.9 vs 83.4±18.1, P=0.373), while a significant improvement was observed in the ST-PVR group after 4 weeks of treatment (83.6±15.2 vs 78.4±15.1, P=0.015). The caloric test results showed that after 8 weeks of treatment, the proportion of patients with unilateral weakness<25% increased in both groups [FVR group: 57.1% (12/21) vs 9.5% (2/21), P=0.001; ST-PVR group: 52.2% (12/23) vs 17.4% (4/23), P=0.014]. In the ST-PVR group, the proportion of patients with dominant preference≤25% significantly increased [91.3% (21/23) vs 60.9% (14/23), P=0.016], while there was no significant change in the FVR group [61.9 (13/21) vs 57.1% (12/21), P=0.500]. The proportion of patients with SOT score≥70 in the ST-PVR group increased significantly after 2 weeks of treatment [69.6% (16/23) vs 30.4% (7/23), P=0.009], while the FVR group showed a significant increase only after 8 weeks of treatment [81.0% (17/21) vs 42.9% (9/21), P=0.012]. Conclusion: Both FVR and ST-PVR effectively promote vestibular compensation by improving objective vestibular functions and relieving subjective symptoms and anxiety of the patients with decompensation recurrent vertigo, while ST-PVR might shorten the recovery time and increase balance confidence.
Collapse
Affiliation(s)
- Y Wang
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University/NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China
| | - H Zhao
- Department of Nuclear Medicine, the Affiliated Taian City Central Hospital of Qingdao University, Taian 100160, China
| | - L Tian
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University/NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China
| | - Y B Huang
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University/NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China
| | - J J Wu
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University/NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China
| | - J Wang
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University/NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China
| |
Collapse
|
2
|
Tang MJ, Zhou LY, Jia XJ, Wu JJ, Lou YB, Jin MJ, Zhu YF. [Randomized controlled study on the application effect of a new type of intravenous radiofrequency closed therapy system made in China and an imported system]. Zhonghua Wai Ke Za Zhi 2024; 62:223-228. [PMID: 38291638 DOI: 10.3760/cma.j.cn112139-20231012-00167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/01/2024]
Abstract
Objective: To compare the application effect of domestic and imported intravenous radiofrequency closure system in the treatment of primary varicose veins of lower extremities. Methods: This single-center prospective, non-inferiority randomized controlled trial was performed in the Department of Vascular Surgery, the Fourth Affiliated Hospital, Zhejiang University School of Medicine from January 2021 to January 2022. Patients with primary varicose veins of lower extremities who met the ataxation criteria were randomly assigned to the experimental group(domestic novel venous radiofrequency closure system) or the control group(imported venous radiofrequency closure system) in a ratio of 1∶1. The two groups of subjects were compared in terms of target vein closure rate, technical success rate, system operation performance, incidence of adverse events and incidence of serious adverse events(SAE) within 6 months after surgery. Quantitative data were compared by Mann-Whitney U test, and categorical data were compared by χ2 test and non-inferiority test. Results: A total of 80 subjects were included in the trial (41 in the experimental group and 39 in the control group), including 27 males and 53 females, aged (M(IQR)) 55(23) years (range:40 to 78 years). There were 48 cases of left lower limb and 32 cases of right lower limb. The technical success rate and system control performance between the groups were 100%.The incidence of adverse events (58.5% (24/41) vs. 61.5% (24/39), χ2=0.075, P=0.784), and the incidence of SAE (7.3% (3/41) vs. 5.1% (2/39), χ2=0.163, P=0.686) within 6 months after surgery in experimental group and control group had no statistical significance. There was one device-related adverse event in each of the two groups. In the experimental group, one patient developed endovenous heat-induced thrombosis after surgery and recovered after taking rivaroxaban tablets. One patient in the control group had pain in the upper right thigh for more than 1 day after operation, which was cured after using analgesic cream. No device-related SAE occurred. The venous closure rate of the experimental group was 100% (38/38) at 6 months after surgery, and that of the control group was 97.4% (37/38). The difference between the two groups was 2.63% (95%CI:-3.19 to 8.45, Z=4.865, P<0.01), and the 95%CI lower limit of the difference in target venous closure rate between two groups was greater than the non-inferiority threshold of -10.00%. Conclusion: The early application effect of the new domestic intravenous radiofrequency closure system in patients with primary varicose veins of lower extremities is in line with expectations, it is not inferior to the imported system.
Collapse
Affiliation(s)
- M J Tang
- Department of Vascular Surgery, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China
| | - L Y Zhou
- Department of Vascular Surgery, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China
| | - X J Jia
- Department of Vascular Surgery, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China
| | - J J Wu
- Department of Vascular Surgery, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China
| | - Y B Lou
- Department of Vascular Surgery, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China
| | - M J Jin
- School of Public Health, Zhejiang University School of Medicine, Hangzhou 310000, China
| | - Y F Zhu
- Department of Vascular Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China
| |
Collapse
|
3
|
Yue XN, He XY, Wu JJ, Fan W, Zhang HJ, Wang CW. Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion. Clin Radiol 2023; 78:e574-e581. [PMID: 37183140 DOI: 10.1016/j.crad.2023.04.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2022] [Revised: 12/06/2022] [Accepted: 04/17/2023] [Indexed: 05/16/2023]
Abstract
AIM To assess the value of semi-quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and quantitative diffusion-weighted imaging parameters combined with human epididymis protein 4 (HE4) in predicting the pathological grade and lymphovascular space invasion (LVSI) of endometrioid adenocarcinoma (EAC). MATERIALS AND METHODS Between October 2018 and December 2021, 60 women (mean age, 55 [range, 32-77] years) with EAC underwent preoperative pelvic MRI and HE4 level measurements. The positive enhancement integral (PEI), time to peak, maximum slope of increase (MSI), and maximum slope of decrease were measured by manually drawing a region of interest on the neoplastic tissue. The receiver operating characteristic curve was used to calculate the diagnostic efficiency of the single parameter and combined factors. RESULTS Lower apparent diffusion coefficients (ADCs) were observed in high-grade tumours (G3) than in low-grade tumours (G1/G2). PEI, MSI, and HE4 levels were higher in the high-grade tumours than in the low-grade tumours (p<0.05). The area under the curve (AUC) for G3 diagnosis using multiparametric MRI combined with HE4 was 0.929. ADC values were significantly lower in the EAC with LVSI than in those without LVSI. Tumours with LVSI showed higher PEI and HE4 levels than those without LVSI (p<0.05). The AUC for LVSI-positive diagnosis using multiparametric MRI combined with HE4 was 0.814. CONCLUSION Semi-quantitative DCE-MRI, ADC values, and serum HE4 levels can be used to predict tumour grade and LVSI, and the prediction efficiency of multiparametric MRI combined with serum HE4 is better than that of any single factor.
Collapse
Affiliation(s)
- X N Yue
- Department of CT/MRI, First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, 832000, China
| | - X Y He
- Department of CT/MRI, First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, 832000, China
| | - J J Wu
- Department of CT/MRI, First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, 832000, China
| | - W Fan
- Department of CT/MRI, First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, 832000, China
| | - H J Zhang
- Department of Pathology, First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, 832000, China
| | - C W Wang
- Department of CT/MRI, First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, 832000, China.
| |
Collapse
|
4
|
Gu YZ, He SP, Wu JJ, Qiao L, Zhao LD, Li MT, Zhao Y, Zeng XF. [A case of Castleman disease mimicking Sjögren's syndrome]. Zhonghua Nei Ke Za Zhi 2023; 62:711-713. [PMID: 37263956 DOI: 10.3760/cma.j.cn112138-20220627-00482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- Y Z Gu
- Department of Internal Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - S P He
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Disease, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
| | - J J Wu
- Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - L Qiao
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Disease, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
| | - L D Zhao
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Disease, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
| | - M T Li
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Disease, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
| | - Y Zhao
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Disease, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
| | - X F Zeng
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Disease, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
| |
Collapse
|
5
|
Yuan H, Yao B, Li JT, Zhu WL, Ren DL, Wang H, Ma TH, Chen SQ, Wu JJ, Tao YR, Ye L, Wang ZY, Qu H, Ma B, Zhong WW, Wang DJ, Qiu JG. [Observational study on perioperative outcomes of pelvic exenteration]. Zhonghua Wei Chang Wai Ke Za Zhi 2023; 26:260-267. [PMID: 36925126 DOI: 10.3760/cma.j.cn441530-20221024-00428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 03/18/2023]
Abstract
Objective: To investigate the surgical indications and perioperative clinical outcomes of pelvic exenteration (PE) for locally advanced, recurrent pelvic malignancies and complex pelvic fistulas. Methods: This was a descriptive study.The indications for performing PE were: (1) locally advanced, recurrent pelvic malignancy or complex pelvic fistula diagnosed preoperatively by imaging and pathological examination of a biopsy; (2)preoperative agreement by a multi-disciplinary team that non-surgical and conventional surgical treatment had failed and PE was required; and (3) findings on intraoperative exploration confirming this conclusion.Contraindications to this surgical procedure comprised cardiac and respiratory dysfunction, poor nutritional status,and mental state too poor to tolerate the procedure.Clinical data of 141 patients who met the above criteria, had undergone PE in the Sixth Affiliated Hospital of Sun Yat-sen University from January 2018 to September 2022, had complete perioperative clinical data, and had given written informed consent to the procedure were collected,and the operation,relevant perioperative variables, postoperative pathological findings (curative resection), and early postoperative complications were analyzed. Results: Of the 141 included patients, 43 (30.5%) had primary malignancies, 61 (43.3%) recurrent malignancies, 28 (19.9%) complex fistulas after radical resection of malignancies,and nine (6.4%)complex fistulas caused by benign disease. There were 79 cases (56.0%) of gastrointestinal tumors, 30 cases (21.3%) of reproductive tumors, 16 cases (11.3%) of urinary tumors, and 7 cases (5.0%) of other tumors such mesenchymal tissue tumors. Among the 104 patients with primary and recurrent malignancies, 15 patients with severe complications of pelvic perineum of advanced tumors were planned to undergo palliative PE surgery for symptom relief after preoperative assessment of multidisciplinary team; the other 89 patients were evaluated for radical PE surgery. All surgeries were successfully completed. Total PE was performed on 73 patients (51.8%),anterior PE on 22 (15.6%),and posterior PE in 46 (32.6%). The median operative time was 576 (453,679) minutes, median intraoperative blood loss 500 (200, 1 200) ml, and median hospital stay 17 (13.0,30.5)days.There were no intraoperative deaths. Of the 89 patients evaluated for radical PE surgery, the radical R0 resection was achieved in 64 (71.9%) of them, R1 resection in 23 (25.8%), and R2 resection in two (2.2%). One or more postoperative complications occurred in 85 cases (60.3%), 32 (22.7%)of which were Clavien-Dindo grade III and above.One patient (0.7%)died during the perioperative period. Conclusion: PE is a valid option for treating locally advanced or recurrent pelvic malignancies and complex pelvic fistulas.
Collapse
Affiliation(s)
- H Yuan
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - B Yao
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - J T Li
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - W L Zhu
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - D L Ren
- Department of Pelvic Floor Diseases, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China
| | - H Wang
- Department of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China
| | - T H Ma
- Department of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China
| | - S Q Chen
- Department of Gynecology, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China
| | - J J Wu
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - Y R Tao
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - L Ye
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - Z Y Wang
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - H Qu
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - B Ma
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - W W Zhong
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - D J Wang
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| | - J G Qiu
- Department of Urology, the Sixth Affiliated Hospital, Sun Yat-sen University,Guangzhou 510655, China
| |
Collapse
|
6
|
Zhan TL, Chen YW, Wu JJ, Li F, Zhang H, Fu LJ. [A case of severe pulmonary hypertension in children treated by transcatheter Potts shunt]. Zhonghua Er Ke Za Zhi 2023; 61:169-171. [PMID: 36720601 DOI: 10.3760/cma.j.cn112140-20220717-00654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Affiliation(s)
- T L Zhan
- Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| | - Y W Chen
- Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| | - J J Wu
- Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| | - F Li
- Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| | - H Zhang
- Department of Cardiovascular and Thoracic Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| | - L J Fu
- Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| |
Collapse
|
7
|
Vittrup I, Frøstrup AG, Gren ST, Thomsen SF, Wu JJ, Schmid-Grendelmeier P, Maul JT, Egeberg A, Thyssen JP. Disease burden of moderate-severe atopic dermatitis by use of systemic treatment: Results from the Danish Skin Cohort. J Eur Acad Dermatol Venereol 2023; 37:e688-e690. [PMID: 36688332 DOI: 10.1111/jdv.18912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Accepted: 01/16/2023] [Indexed: 01/24/2023]
Affiliation(s)
- I Vittrup
- Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
| | | | - S T Gren
- Pfizer Denmark, Ballerup, Denmark
| | - S F Thomsen
- Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
| | - J J Wu
- Department of Dermatology, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - P Schmid-Grendelmeier
- Department of Dermatology and Venereology, University Hospital of Zurich, Zurich, Switzerland
| | - J-T Maul
- Department of Dermatology and Venereology, University Hospital of Zurich, Zurich, Switzerland.,Faculty of Medicine, University of Zurich, Zurich, Switzerland
| | - A Egeberg
- Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
| | - J P Thyssen
- Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
| |
Collapse
|
8
|
Yu XW, Zhou JZ, Xu EW, Liu JY, Li MC, Wu JJ, Yang QY. [Expression and regulatory role of ultraconserved long non-coding RNA uc.77 in lung cancer]. Zhonghua Zhong Liu Za Zhi 2022; 44:1102-1111. [PMID: 36319456 DOI: 10.3760/cma.j.cn112152-20200730-00693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objective: To investigate the effect and molecular mechanism of ultra-conservative long non-coding RNA uc.77 in lung cancer. Methods: Lung cancer tissues and adjacent normal tissues were obtained from 61 patients with lung cancer who were diagnosed with lung cancer and underwent surgery from 2014 to 2016 in the General Hospital of the Southern Theater Command of the People's Liberation Army. Real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) was used to detect the uc.77 relative expressions in normal human bronchial epithelial cells 16HBE, lung cancer cell lines, and 61 pair lung cancer tissues. Uc.77 siRNA was transfected into lung cancer cells to interfere with the expression of uc.77, qRT-PCR was used to verify the interference effect, CCK8 method and clone formation experiment were used to detect cell proliferation ability, flow cytometry was used to detect apoptosis and cell cycle changes. H1299 cells transfected with uc.77 siRNA were injected into the subcutaneous right side of BALB/c nude mice to construct a tumor-bearing model for exploring the role of uc.77 on tumor growth. Western blot and qRT-PCR methods were used to detect the protein and mRNA expressions of p21. Results: The relative expression levels of uc.77 in lung cancer cell lines 95D, H1299, A549, H460, H446 and 16HBE-T were significantly higher than that of 16HBE cells (P<0.05). The uc.77 RNA expression levels of lung cancer tissues was significantly higher than that of the adjacent normal tissues (P<0.001). In addition, increased lncRNA uc.77 expression was significantly associated with big tumor size, lymph node metastasis and advanced TNM stage (P<0.05). After transfection with uc.77 siRNA, the expressions of uc.77 in H1299, 95-D and 16HBE-T cells were reduced (P<0.05), and the cell proliferation capacities were reduced at 48 hours and 72 hours (P<0.05). After transfection with uc.77 siRNA-1, the G(0)/G(1) phase cell ratio of H1299 siRNA-1 group [(71.86±3.46)%] was higher than those of H1299-control group [(47.62±5.48)%] and H1299 siRNA-NC group [(61.38±5.62)%, P<0.05], S phase cell ratio of H1299 siRNA-1 group [(14.99±3.61)%] was lower than those of H1299-control group [(34.95±7.05)%] and H1299 siRNA-NC group [(23.75±5.87)%, P<0.05], the apoptosis rate of H1299 siRNA-1 group [(4.90±1.80)%] was higher than those of H1299-control group [(3.30±0.80)%] and H1299 siRNA-NC group [(2.80±1.20)%, P<0.05], the colony formation rate of H1299 siRNA-1 group [(19.20±2.00)%] was lower than those of H1299 control group [(32.60±2.00)%] and H1299 siRNA-NC group [(34.40±1.00)%, P<0.05]. The results of the nude mice tumor formation experiment showed that the tumor volume of the H1299 siRNA-1 group was significantly lower than those of the H1299-control group and the H1299-negative control group (P<0.05), the average tumor weight of H1299 siRNA-1 group was significantly lower than those of H1299-control group and H1299-negative control group (P<0.05), tumor cell growth marker Ki-67 in the H1299 siRNA-1 group showed weak positive, and Ki-67 in the H1299-control group and H1299-negative control group showed positive. The result of qRT-PCR analysis showed that the mRNA expression level of p21 in H1299 siRNA-1 group (2.57±0.45) was higher than those in H1299 control group (1.00±0.00, P=0.001) and H1299 siRNA-NC group (1.52±0.37, P=0.009). The result of western blotting analysis also showed that the expression of p21 protein level in H1299 siRNA-1 group increased. Conclusions: The expression of ultraconserved long non-coding RNA uc.77 is elevated in lung cancer cell lines and lung cancer tissues. Silencing the expression of ultraconservative long noncoding RNA uc.77 can inhibit tumor growth, and blocking uc.77 expression may be a potential therapeutic target for lung cancer.
Collapse
Affiliation(s)
- X W Yu
- Institute of Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 511436, China
| | - J Z Zhou
- Institute of Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 511436, China
| | - E W Xu
- Department of Thoracic Surgery, General Hospital of the Southern Theater Command of the PLA, Guangzhou 510010, China
| | - J Y Liu
- Institute of Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 511436, China
| | - M C Li
- Institute of Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 511436, China
| | - J J Wu
- Institute of Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 511436, China
| | - Q Y Yang
- Institute of Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 511436, China
| |
Collapse
|
9
|
Chen XQ, Jia XY, Wu JJ, Huang M, Sun W, Ji N. [Efficacy and safety of omalizumab in patients with refractory allergic asthma: a meta-analysis]. Zhonghua Yi Xue Za Zhi 2022; 102:2201-2209. [PMID: 35872585 DOI: 10.3760/cma.j.cn112137-20211109-02480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To evaluate the efficacy and safety of omalizumab in patients with refractory allergic asthma using meta-analysis. Methods: We searched databases including PubMed, Web of Science, Embase and the website of ClinicalTrials. gov registry for randomized controlled trials (RCTs), using the search terms: ("anti-IgE" OR "anti-immunoglobulin E" OR "anti-IgE antibody" OR "omalizumab" OR "rhuMAb-E25" OR "Xolair") AND ("allergic asthma"). The time was up to September 19th 2020. Review Manager 5.4 software and Stata16 software were used to calculate pooled RR or WMD, perform heterogeneity test, and assess publication bias. Results: Fifteen RCTs with 6 316 patients in total (omalizumab, n=3 469; placebo, n=2 847) met our selection criteria. Comparing with placebo, omalizumab reduced the risk of asthma exacerbations during both stable-inhaled corticosteroid (ICS) phase (RR=0.69, 95%CI: 0.63-0.75, P<0.001; I2=39.0%, P=0.090) and ICS-reduction phase (RR=0.55, 95%CI: 0.46-0.66, P<0.001; I2=41.0%, P=0.180), reduced emergency visits (RR=0.53, 95%CI: 0.38-0.73, P<0.001; I2=0, P=0.420), made a significant reduction in dosage of ICS (RR=1.35, 95%CI: 1.25-1.45, P<0.001; I2=22.0%, P=0.280) and even withdrew from ICS completely (RR=1.80, 95%CI: 1.41-2.31, P<0.001; I2=57.0%, P=0.070). Omalizumab significantly improved asthma-related quality of life (RR=1.81, 95%CI: 1.51-2.17). The use of rescue bronchodilators was significantly reduced in the omalizumab group (RR=0.78, 95%CI: 0.67-0.92) but there was no significant difference in the dosage of rescue bronchodilators (puff per day) (WMD=-0.32, 95%CI: -0.77-0.13). Patients taking omalizumab did not increase the frequency of any adverse events (RR=1.01, 95%CI: 0.98-1.03) and serious adverse events (RR=0.89, 95%CI: 0.74-1.06). Conclusions: Omalizumab is an ideal adjunctive treatment for refractory allergic asthma with good efficacy and safety. Further randomized controlled trials are needed to determine the appropriate duration of treatment.
Collapse
Affiliation(s)
- X Q Chen
- Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - X Y Jia
- Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - J J Wu
- Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - M Huang
- Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - W Sun
- Department of Respiratory and Critical Care Medicine, Xishan People's Hospital of Wuxi City, Wuxi 214000, China
| | - Ningfei Ji
- Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| |
Collapse
|
10
|
Oulee A, Norden A, Javadi SS, Wu JJ. Skincare influencers and skin problems in social media. J Eur Acad Dermatol Venereol 2022; 36:e819-e821. [PMID: 35686632 DOI: 10.1111/jdv.18305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Accepted: 06/03/2022] [Indexed: 11/29/2022]
Affiliation(s)
- A Oulee
- Dermatology Research and Education Foundation, Irvine, CA, USA.,University of California Riverside School of Medicine, Riverside, CA, USA
| | - A Norden
- Dermatology Research and Education Foundation, Irvine, CA, USA.,Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA
| | - S S Javadi
- Dermatology Research and Education Foundation, Irvine, CA, USA.,David Geffen School of Medicine, University of California, Los Angeles, CA, USA
| | - J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| |
Collapse
|
11
|
Huang T, Zou SL, Shen X, Jin J, Bai J, Wu JJ, Wang L, Jiang QJ, Qu LF. [Evaluation of the level of carotid bifurcation and the morphology of extracranial internal carotid artery in patients with carotid stenosis by color doppler ultrasound and digital subtraction angiography]. Zhonghua Yi Xue Za Zhi 2022; 102:781-786. [PMID: 35325957 DOI: 10.3760/cma.j.cn112137-20210605-01285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To evaluate the value of color Doppler ultrasound and digital subtraction angiography (DSA) in evaluating the level of carotid bifurcation and the morphology of extracranial internal carotid artery in patients with atherosclerotic carotid stenosis. Methods: The carotid artery examination data of 186 patients with atherosclerotic carotid stenosis who underwent carotid DSA and color Doppler ultrasound in Shanghai Changzheng Hospital from July 2017 to June 2019 were retrospectively analyzed, including 154 males and 32 females, with ages ranging from 36 to 84 (66±8) years old. The correlation between the position of carotid bifurcation and the level of cervical spine, the distance from the position of carotid bifurcation to mandibular angle, the correlation of the level of bifurcation with the length of neck, and the incidence of carotid distortion were analyzed. Results: DSA showed that the most common position of carotid bifurcation was at C3 level on the left [37.3% (56/150)], and at C3-C4 level on the right [33.6% (42/125)], and the highest position was at C2 level on the left, and at C2-C3 levels on the right, while the lowest level on both sides was at C5 level. The incidence of high bifurcation of left carotid artery (C3 and above) was 46% (69/150), which was higher than that of right carotid artery [21.6% (27/125), P<0.001]. The incidence of high carotid bifurcation in men and women was 33.2% (76/229) and 43.5% (20/46), respectively, with no significant difference (P = 0.182). Carotid ultrasound showed that the distance between the left carotid bifurcation and the mandibular angle was (3.0±1.3) cm, which was shorter than that on the right [(3.4±1.2) cm] (P<0.001). The distance between carotid bifurcation and mandibular angle in men and women was (3.2±1.2) cm and (3.3±1.0) cm, respectively, with no significant difference (P = 0.093). There was no significant correlation between carotid bifurcation level and carotid length (right: r = 0.02, P = 0.091; left: r = 0.01, P = 0.927). The incidence of carotid artery distortion was 28.1% (9/32) in women and 15.6% (24/154) in men, with no significant difference (P = 0.091). The incidence of right carotid artery distortion in high bifurcation group was 59.3% (16/27), which was higher than that in non-high bifurcation group [3.1% (3/98)] (P<0.001). Likewise, the incidence of left carotid artery distortion in high bifurcation group was 30.4% (21/69), which was higher than that in non-high bifurcation group [2.5% (2/81)] (P<0.001). Conclusions: The bifurcation position of left carotid artery in patients with atherosclerotic carotid stenosis is higher than that of the right. Patients with high bifurcation of carotid artery are more likely to be complicated with carotid distortion. Preoperative color doppler ultrasound combined with DSA can evaluate the distortion of extracranial carotid artery, thereby providing reference for the selection of surgical methods.
Collapse
Affiliation(s)
- T Huang
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| | - S L Zou
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| | - X Shen
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| | - J Jin
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| | - J Bai
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| | - J J Wu
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| | - L Wang
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| | - Q J Jiang
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| | - L F Qu
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
| |
Collapse
|
12
|
Wu JJ, Kavanaugh A, Lebwohl MG, Gniadecki R, Merola JF. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J Eur Acad Dermatol Venereol 2022; 36:797-806. [PMID: 35238067 PMCID: PMC9313585 DOI: 10.1111/jdv.18044] [Citation(s) in RCA: 33] [Impact Index Per Article: 16.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Accepted: 02/11/2022] [Indexed: 11/28/2022]
Abstract
Psoriasis is a chronic systemic inflammatory disorder associated with several comorbidities in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent comorbidity in psoriasis and a risk factor for cardiovascular disease, a major cause of death among patients with psoriasis. Although the exact causal relationship between these two disorders is not fully established, the underlying pathophysiology linking psoriasis and MetS seems to involve overlapping genetic predispositions and inflammatory pathways. Dysregulation of the IL‐23/Th‐17 immune signalling pathway is central to both pathologies and may be key to promoting susceptibility to metabolic and cardiovascular diseases in individuals with and without psoriasis. Thus, biological treatments for psoriasis that interrupt these signals could both reduce the psoriatic inflammatory burden and also lessen the risk of developing atherosclerosis and cardiometabolic diseases. In support of this hypothesis, improvement of skin lesions was associated with improvement in vascular inflammation in recent imaging studies, demonstrating that the beneficial effect of biological agents goes beyond the skin and could help to prevent cardiovascular disease. This review will summarize current knowledge on underlying inflammatory mechanisms shared between psoriasis and MetS and discuss the most recent clinical evidence for the potential for psoriasis treatment to reduce cardiovascular risk.
Collapse
Affiliation(s)
- J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| | - A Kavanaugh
- University of California San Diego, San Diego, CA, USA
| | - M G Lebwohl
- Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York, NY, USA
| | - R Gniadecki
- Division of Dermatology, University of Alberta, Edmonton, AB, Canada
| | - J F Merola
- Department of Medicine, Division of Rheumatology and Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
13
|
Qiao XF, Liu L, Wu JH, Li M, Yu JL, Li X, Lyu XH, Wu JJ. [Genotyping analysis of norovirus infectious diarrhea clusters in Songjiang district, Shanghai from 2017 to 2019]. Zhonghua Yu Fang Yi Xue Za Zhi 2021; 55:1316-1320. [PMID: 34749475 DOI: 10.3760/cma.j.cn112150-20210907-00878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: We aimed to analyze the the genotyping of norovirus infectious diarrhea epidemic in Songjiang district, Shanghai, and explored the experience in handling the epidemic to provide a scientific basis for formulating prevention and treatment strategies. Methods: The epidemiological data and related samples of 69 outbreaks of infectious diarrhea caused by norovirus was collected from 2017 to 2019 in Songjiang district, Shanghai. Sequencing and type identification were performed by the method of gene sequencing for the junction region of Norovirus ORF1 and ORF2. Results: From 2017 to 2019, 69 outbreaks of norovirus infections diarrhea were reported in Songjiang district, Shanghai. A total of 1 767 samples were tested, including 619 case samples (positive rate 19.9%), 343 practitioner samples (positive rate 1.1%), 505 environmental samples (positive rate 0.5%) and 300 food samples (not detected). 141 sequences were obtained, and the genotype analysis showed that the genotype that mainly caused infectious diarrhea in 2017 and 2018 was GII.P16-GII.2 (50.98%, 26/51). In 2019, the genotypes that mainly caused infectious diarrhea were GII.P16-GII.2 (13.73%, 7/51) and GII.Pe-GII.4 (9.80%, 5/51). Conclusion: The main genotype of the 69 outbreaks of nororirus infectious diarrhea epidemic in Songjiang district, Shanghai from 2017 to 2019 was GII.P16-GII.2, which showed obvious peaks in spring, autumn and winter. There were more infections in kindergartens and schools. The surveillance of norovirus infection should be strengthened.
Collapse
Affiliation(s)
- X F Qiao
- Shanghai Songjiang Center for Disease Control and Prevention, Shanghai 201620, China
| | - L Liu
- Shanghai Songjiang Center for Disease Control and Prevention, Shanghai 201620, China
| | - J H Wu
- Shanghai Songjiang Center for Disease Control and Prevention, Shanghai 201620, China
| | - M Li
- Shanghai Songjiang Center for Disease Control and Prevention, Shanghai 201620, China
| | - J L Yu
- Shanghai Songjiang Center for Disease Control and Prevention, Shanghai 201620, China
| | - X Li
- Shanghai Songjiang Center for Disease Control and Prevention, Shanghai 201620, China
| | - X H Lyu
- Shanghai Songjiang Center for Disease Control and Prevention, Shanghai 201620, China
| | - J J Wu
- Shanghai Songjiang Center for Disease Control and Prevention, Shanghai 201620, China
| |
Collapse
|
14
|
Gordon KB, Lebwohl M, Papp KA, Bachelez H, Wu JJ, Langley RG, Blauvelt A, Kaplan B, Shah M, Zhao Y, Sinvhal R, Reich K. Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis. Br J Dermatol 2021; 186:466-475. [PMID: 34652810 PMCID: PMC9298814 DOI: 10.1111/bjd.20818] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/14/2021] [Indexed: 01/14/2023]
Abstract
Background Risankizumab has demonstrated efficacy and safety in patients with moderate‐to‐severe plaque psoriasis in randomized clinical trials. Objectives To evaluate safety data from risankizumab psoriasis phase I–III clinical trials. Methods Short‐term safety (through week 16) was analysed using integrated data from five phase II and III clinical trials. Long‐term safety was evaluated using integrated data from 17 phase I–III completed and ongoing trials. Results Short‐term safety analyses included 1306 patients receiving risankizumab 150 mg and 300 patients receiving placebo [402·2 and 92·0 patient‐years (PY) of exposure, respectively]. Long‐term analyses included 3072 risankizumab‐treated patients (exposure: 7927 PY). The median (excluding four outliers) treatment duration was 2·9 years (range 2 days to 5·9 years). Exposure‐adjusted adverse event rates did not increase with long‐term treatment (318 vs. 171 events per 100 PY for short‐ and long‐term analyses). With long‐term risankizumab treatment, rates of serious adverse events were 7·8 per 100 PY, serious infections 1·2 per 100 PY, nonmelanoma skin cancer (NMSC) 0·7 per 100 PY, malignant tumours excluding NMSC 0·5 per 100 PY, and adjudicated major adverse cardiovascular events 0·3 per 100 PY, with no important identified risks. Limitations include that the study inclusion and exclusion criteria varied and that three studies enrolled ≤ 50 patients. Conclusions Risankizumab demonstrated a favourable safety profile over short‐ and long‐term treatment in patients with moderate‐to‐severe psoriasis. Whatis already known about this topic? In clinical trials of patients with moderate‐to‐severe plaque psoriasis, risankizumab, a selective interleukin‐23 inhibitor, was well tolerated and efficacious.
Whatdoes this study add? In this comprehensive evaluation of risankizumab safety in patients with moderate‐to‐severe psoriasis, adverse event rates were comparable between risankizumab (n = 1306, 402 patient‐years) and placebo (n = 300, 92 patient‐years) in the short‐term (16‐week) analysis set, and were consistent with those in the long‐term analysis (n = 3072, 7927 patient‐years of risankizumab exposure). These findings are consistent with the known safety profile of risankizumab and support its long‐term use in moderate‐to‐severe psoriasis.
Linked Comment: S. Mirali et al. Br J Dermatol 2022; 186:394–395. Plain language summary available online
Collapse
Affiliation(s)
- K B Gordon
- Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA
| | - M Lebwohl
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - K A Papp
- K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada
| | - H Bachelez
- Hôpital Saint-Louis, AP-HP, Université de Paris, Paris, France
| | - J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| | - R G Langley
- Division of Dermatology, Department of Medicine, Dalhousie University, Halifax, NS, Canada
| | - A Blauvelt
- Oregon Medical Research Center, Portland, OR, USA
| | - B Kaplan
- AbbVie Inc., North Chicago, IL, USA
| | - M Shah
- AbbVie Inc., North Chicago, IL, USA
| | - Y Zhao
- AbbVie Inc., North Chicago, IL, USA
| | | | - K Reich
- Center for Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
15
|
Qu LF, Bai J, Wu JJ, Wang L. [The new classification and treatment of neck hemorrhage]. Zhonghua Yi Xue Za Zhi 2021; 101:2267-2270. [PMID: 34333940 DOI: 10.3760/cma.j.cn112137-20210109-00065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Neck is an important and complex region of the human body. Once injury occurs, it often leads to a high mortality rate and complication rate, among which vascular injury and massive hemorrhage are the main causes. However, due to the particularity of neck structure, there is a lack of effective control methods for cervical vascular hemorrhage, and there is still no consensus on the diagnosis and treatment of cervical vascular hemorrhage. Combined with the newest researches, this paper tries to explore and summarize the experience of the new classification and management principle of vascular massive hemorrhage.
Collapse
Affiliation(s)
- L F Qu
- Department of Vascular & Endovascular Surgery, Changzheng Hospital, Naval Medical University,Shanghai 200003,China
| | - J Bai
- Department of Vascular & Endovascular Surgery, Changzheng Hospital, Naval Medical University,Shanghai 200003,China
| | - J J Wu
- Department of Vascular & Endovascular Surgery, Changzheng Hospital, Naval Medical University,Shanghai 200003,China
| | - L Wang
- Department of Vascular & Endovascular Surgery, Changzheng Hospital, Naval Medical University,Shanghai 200003,China
| |
Collapse
|
16
|
Wu JJ, Xiang B, Bai J, Li WW, Liu YJ, Xiang H, Qu LF. [Analysis of types and treatment methods of cervical massive hemorrhage]. Zhonghua Yi Xue Za Zhi 2021; 101:2283-2287. [PMID: 34333942 DOI: 10.3760/cma.j.cn112137-20210109-00063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To summarize the classification and clinical treatment experience of cervical massive hemorrhage in multiple centers. Methods: From April 2012 to October 2020, clinical data of 42 patients with cervical massive hemorrhage were retrospectively analyzed, including 27 cases from Shanghai Changzheng Hospital, 7 cases from Hunan Provincial People's Hospital, 4 cases from Longkou People's Hospital and 4 cases from Laizhou People's Hospital. According to bleeding position (P), bleeding vessel (V), cerebral blood supply (C), and the presence or absence of associated injury (A), 42 patients were classified as "PVCA", and summarize the methods of pre-hospital emergency and in-hospital treatment based on the "ABC" treatment principles: airway rebuild (A), effective arterial hemostasis and bleeding stop (B), and cerebral blood flow reconstruction within the time window (C). Results: Within the 42 cases of cervical massive hemorrhage, there were 3 cases of type P1 (below cricoid cartilage), 28 cases of type P2 (cricoid cartilage-mandibular angle), 11 cases of type P3 (mandibular angle-skull base); 22 cases of type V1 (arterial hemorrhage), 11 cases of type V2 (main venous hemorrhage), 7 cases of type V3 (simple superficial vein or small artery hemorrhage), 2 cases of type V4 (mixed arteriovenous hemorrhage); 5 cases of type C0 (no symptoms of cerebral ischemia and neurological dysfunction), 33 cases of type C1 (transient cerebral ischemia without sensory disturbance), 4 cases of type C2 (symptoms of cerebral ischemia and neurological dysfunction); 39 cases of type A0 (no other system damage was involved) and 3 cases of type A1 (combined with other system damage). All 42 patients received operations, 25 patients received open surgery of vascular reconstruction+hematoma/foreign body removal (7 cases of vascular ligation, 14 cases of direct suture repair, 4 cases of vascular interposition), 17 patients received hybrid surgery (carotid angiography+covered stent repair+hematoma/foreign body removal). The surgical technique success rate the was 100%. All the hemorrhagic shock was corrected, hematoma compression was relieved, and the symptoms of cephalic ischemia were improved. There were 4 cases of local cranial nerve injury, 1 case of incision hematoma and 6 cases of postoperative hyper perfusion. During the average 14.3 months follow-up, there was no operation related myocardial infarction, stroke or death, no re-rupture or re-dissection, and 50% asymptomatic restenosis was found in 1 case one year after received covered stent endovascular repair. Conclusion: Based on the "PVCA" classification and "ABC" treatment principle, it is safe and effective to rescue cervical massive hemorrhage.
Collapse
Affiliation(s)
- J J Wu
- Department of Vascular & Endovascular Surgery, Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China
| | - B Xiang
- Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital, Changsha 410005, China
| | - J Bai
- Department of Vascular & Endovascular Surgery, Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China
| | - W W Li
- Department of Vascular & Endovascular Surgery, Longkou People's Hospital, Longkou 265701, China
| | - Y J Liu
- Department of Cardiovascular Surgery, Laizhou People's Hospital, Laizhou 261400, China
| | - H Xiang
- Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital, Changsha 410005, China
| | - L F Qu
- Department of Vascular & Endovascular Surgery, Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China
| |
Collapse
|
17
|
Thaçi D, Jullien D, Egeberg A, Carrascosa JM, Wu JJ, Pau-Charles I, Gisondi P. Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials. J Eur Acad Dermatol Venereol 2021; 35:e709-e711. [PMID: 34058035 DOI: 10.1111/jdv.17427] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2021] [Accepted: 04/28/2021] [Indexed: 11/26/2022]
Affiliation(s)
- D Thaçi
- Institute and Comprehensive Centre for Inflammation Medicine, University of Lübeck, Lübeck, Germany
| | - D Jullien
- Department of Dermatology, Edouard Herriot Hospital, Lyon, France
| | - A Egeberg
- Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark
| | - J M Carrascosa
- Department of Dermatology, Germans Trias i Pujol University Hospital (HUGTP), Autonomous University of Barcelona (UAB), Badalona, Spain
| | - J J Wu
- Dermatology Research and Education Foundation, Irvine, California, USA
| | | | - P Gisondi
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy
| |
Collapse
|
18
|
Lyu YY, Wu JJ, Guo W, Peng L, Wang YX, Wu M, Cao K, Jie Y. [Clinical observation and analysis on the effect of orthokeratology in myopic anisometropic children]. Zhonghua Yu Fang Yi Xue Za Zhi 2021; 55:471-477. [PMID: 33858058 DOI: 10.3760/cma.j.cn112150-20210203-00119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the clinical effects of orthokeratology lens on children with myopic anisometropia. Methods: Retrospective case series study. The data of 226 myopic anisometropia children, (10.83±1.56)years old, including 95 males and 131 females, fitted with orthokeratology(OK) lens in Beijing Tongren Hospital from June 2017 to June 2019 were collected. According to the lens wearing condition and baseline anisometropia, they were divided into four groups: group A1 with an average age of (10.68±1.66) years (bilateral OK lens wearing with low anisometropia, 1.0 D≤SE difference<2.5 D, 50 males and 61 females), group A2 with an average age of (11.24±1.38) years (bilateral OK lens wearing with moderate and high anisometropia, SE difference≥2.5 D, 10 males and 23 females), group B1 with an average age of (10.79±1.51) years (unilateral OK lens wearing with low anisometropia, 1.0 D≤SE difference<2.5 D, 17 males and 21 females) and group B2 with an average age of (10.97±1.60) years (unilateral OK lens wearing with moderate and high anisometropia, SE difference≥2.5 D, 18 males and 26 females). After wearing OK lens for one year, the changes of axial length(AL) and AL difference were observed and statistically analyzed. Results: (1) AL changes: after wearing OK-lens for one year, AL of each eye increased. In group A1, the AL of the more myopic eyes and the less myopic eyes increased by (0.20±0.21) mm and (0.24±0.22) mm respectively, and the difference was statistically significant (t=-3.208, P=0.002); in group A2, the AL growth of the more myopic eyes and the less myopic eyes were (0.04±0.11) mm and (0.17±0.14) mm, and the difference was statistically significant (t=-5.545, P<0.001). In group B1, the AL elongation of the more myopic eyes and the less myopic eyes were (0.14±0.21) mm and (0.39±0.23) mm, and in group B2, the AL growth of the more myopic eyes and the less myopic eyes were (0.11±0.14) mm and (0.54±0.24) mm, with statistically significant differences(t=-6.533, -11.643; all P<0.001). There was a linear correlation between AL elongation and age of the more myopic eyes and the less myopic eyes in group A1(corrected R2=0.208, 0.237) and group A2 (corrected R2=0.169, 0.360). There was no linear correlation of the more myopic eyes and the less myopic eyes between AL change and age or baseline myopia in group B1 (F=0.514, 1.205;P=0.602, 0.312) and group B2 (F=0.841, 0.056; P=0.439, 0.946). (2)Change of AL difference: after wearing OK lens for one year, the changes of AL difference in groupA1, A2, B1 and B2 were (-0.04±0.14) mm,(-0.13±0.13) mm,(-0.26±0.24) mm and (-0.43±0.25) mm, and the decrease of AL difference in moderate and high anisometropia groups were greater than that in low anisometropia groups (t =-3.211, -3.180; P=0.002, 0.002).There was a linear correlation between the reduction of AL difference and baseline anisometropia in group A1, A2 and B2 (corrected R2=0.099, 0.149, 0.230), and there was no linear relationship between the decrease of AL difference and the baseline anisometropia in group B1 (F=0.014, P=0.908). Conclusions: Orthokeratology could effectively control the progression of myopia and to treat anisometropia. The effect of myopia control was better in the older binocular OK lens wearers, and for the patients with greater baseline anisometropia, the treatment effect of anisometropia was better.
Collapse
Affiliation(s)
- Y Y Lyu
- Tongren Vision Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - J J Wu
- Tongren Vision Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - W Guo
- Tongren Vision Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - L Peng
- Tongren Vision Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - Y X Wang
- Tongren Vision Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - M Wu
- Tongren Vision Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - K Cao
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University/Beijing Institute of Ophthalmology/Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100730, China
| | - Y Jie
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University/Beijing Institute of Ophthalmology/Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100730, China
| |
Collapse
|
19
|
Wu JJ, Kearns DG, Lin TC, Chat VS, Litman HJ, Dube B, McLean RR. Characterization of non-responders to interleukin-17 inhibitors in moderate to severe psoriasis patients enrolled in the Corrona ® Psoriasis Registry. J Eur Acad Dermatol Venereol 2021; 35:e531-e533. [PMID: 33834554 DOI: 10.1111/jdv.17270] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| | - D G Kearns
- Loma Linda University School of Medicine, Loma Linda, CA, USA
| | - T-C Lin
- Corrona LLC, Waltham, MA, USA
| | - V S Chat
- Medical College of Georgia at Augusta University, Augusta, CA, USA
| | | | - B Dube
- Corrona LLC, Waltham, MA, USA
| | | |
Collapse
|
20
|
Wu JJ, Wang JL, Tung CF, Tseng JS. Suppurative mediastinal lymphadenitis caused by Actinomyces odontolyticus: Successfully diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. J Postgrad Med 2021; 67:46-48. [PMID: 33533749 PMCID: PMC8098874 DOI: 10.4103/jpgm.jpgm_739_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- J J Wu
- Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
| | - J L Wang
- Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
| | - C F Tung
- Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
| | - J S Tseng
- Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
| |
Collapse
|
21
|
Liu J, Martin A, Thatiparthi A, Wu JJ. Association between atopic dermatitis and osteoarthritis among US adults in the 1999-2006 NHANES. J Eur Acad Dermatol Venereol 2021; 35:e375-e377. [PMID: 33540471 DOI: 10.1111/jdv.17147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2020] [Revised: 01/06/2021] [Accepted: 01/28/2021] [Indexed: 11/30/2022]
Affiliation(s)
- J Liu
- Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - A Martin
- School of Medicine, University of California Riverside, Riverside, CA, USA
| | - A Thatiparthi
- Western University of Health Sciences, Pomona, CA, USA
| | - J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| |
Collapse
|
22
|
Li Z, Gao JR, Song L, Wang PG, Ren JA, Wu XW, Luo SM, Zeng QJ, Weng YH, Xu XJ, Yuan QZ, Zhao J, Liao NS, Mai W, Wang F, Cao H, Wang SC, Han G, Wang DR, Wang H, Zhang J, Zhang H, Zhang DM, Liao WS, Zhao WW, Li W, Cui P, Chen X, Zhang HY, Yang T, Wang L, Gao YS, Li J, Wu JJ, Zhou W, Lyu ZJ, Fang J. [Risk factors for surgical site infection after emergency abdominal surgery: a multicenter cross-sectional study in China]. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23:1043-1050. [PMID: 33212552 DOI: 10.3760/cma.j.issn.441530-20200527-00315] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: Surgical site infection (SSI) is the most common infectious complication after emergency abdominal surgery (EAS). To a large extent, most SSI can be prevented, but there are few relevant studies in China. This study mainly investigated the current situation of SSI occurrence after EAS in China, and further explored risk factors for SSI occurrence. Methods: Multi-center cross-sectional study was conducted. Clinical data of patients undergoing EAS in 33 hospitals across China between May 1, 2019 and June 7, 2019 were prospectively collected, including perioperative data and microbial culture results from infected incisions. The primary outcome was the incidence of SSI after EAS, while the secondary outcomes were postoperative hospital stay, ICU occupancy rate, length of ICU stay, hospitalization cost, and mortality within postoperative 30 days. Univariate and multivariate logistic regression models were used to analyze the risk factors of SSI after EAS. Results: A total of 660 EAS patients aged (47.9±18.3) years were enrolled in this study, including 56.5% of males (373/660). Forty-nine (7.4%) patients developed postoperative SSI. The main pathogen of SSI was Escherichia coli [culture positive rate was 32.7% (16/49)]. As compared to patients without SSI, those with SSI were more likely to be older (median 56 years vs. 46 years, U=19 973.5, P<0.001), male [71.4% (35/49) vs. 56.1% (343/611), χ(2)=4.334, P=0.037] and diabetes [14.3% (7/49) vs. 5.1% (31/611), χ(2)=5.498, P=0.015]; with-lower preoperative hemoglobin (median: 122.0 g/L vs. 143.5 g/L, U=11 471.5, P=0.006) and albumin (median: 35.5 g/L vs. 40.8 g/L, U=9452.0, P<0.001), with higher blood glucose (median: 6.9 mmol/L vs. 6.0 mmol/L, U=17 754.5, P<0.001); with intestinal obstruction [32.7% (16/49) vs. 9.2% (56/611), χ(2)=25.749, P<0.001], with ASA score 3-4 [42.9% (21/49) vs. 13.9% (85/611), χ(2)=25.563, P<0.001] and with high surgical risk [49.0% (24/49) vs. 7.0% (43/611), χ(2)=105.301, P<0.001]. The main operative procedure resulting in SSI was laparotomy [81.6%(40/49) vs. 35.7%(218/611), χ(2)=40.232, P<0.001]. Patients with SSI experienced significantly longer operation time (median: 150 minutes vs. 75 minutes, U=25 183.5, P<0.001). In terms of clinical outcome, higher ICU occupancy rate [51.0% (25/49) vs. 19.5% (119/611), χ(2)=26.461, P<0.001], more hospitalization costs (median: 44 000 yuan vs. 15 000 yuan, U=24 660.0, P<0.001), longer postoperative hospital stay (median: 10 days vs. 5 days, U=23 100.0, P<0.001) and longer ICU occupancy time (median: 0 days vs. 0 days, U=19 541.5, P<0.001) were found in the SSI group. Multivariate logistic regression analysis showed that the elderly (OR=3.253, 95% CI: 1.178-8.985, P=0.023), colorectal surgery (OR=9.156, 95% CI: 3.655-22.937, P<0.001) and longer operation time (OR=15.912, 95% CI:6.858-36.916, P<0.001) were independent risk factors of SSI, while the laparoscopic surgery (OR=0.288, 95% CI: 0.119-0.694, P=0.006) was an independent protective factor for SSI. Conclusions: For patients undergoing EAS, attention should be paid to middle-aged and elderly patients and those of colorectal surgery. Laparoscopic surgery should be adopted when feasible and the operation time should be minimized, so as to reduce the incidence of SSI and to reduce the burden on patients and medical institutions.
Collapse
Affiliation(s)
- Z Li
- Department of Emergency Surgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China
| | - J R Gao
- Department of Emergency Surgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China
| | - L Song
- Department of Emergency Surgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China
| | - P G Wang
- Department of Emergency Surgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China
| | - J A Ren
- Research Institute of General Surgery, East War Zone Hospital of PLA, Nanjing, Jiangsu 210002, China
| | - X W Wu
- Research Institute of General Surgery, East War Zone Hospital of PLA, Nanjing, Jiangsu 210002, China
| | - S M Luo
- Department of Gastrointestinal Surgery, the People's Hospital of Xinjiang Uygur Autonomous Region, Urumq, Xinjiang 830001, China
| | - Q J Zeng
- Department of General Surgery, Yueyang First People's Hospital, Yueyang, Hunan 414000, China
| | - Y H Weng
- Department of General Surgery, Shoukang Hospital, Huangshan, Anhui 245000, China
| | - X J Xu
- Department of General Surgery, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830001, China
| | - Q Z Yuan
- Department of Hepatobiliary Surgery, Shengli Oilfield Central Hospital, Dongying, Shandong 257000, China
| | - J Zhao
- Department of General Surgery, Shangqiu First People's Hospital, Shangqiu, Henan 476000, China
| | - N S Liao
- Department of General Surgery, Taizhou First People's Hospital, Taizhou, Zhejiang 318000, China
| | - W Mai
- Department of Gastrointestinal Surgery, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi 530021, China
| | - F Wang
- Department of Gastrointestinal Surgery, the Affiliated Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China
| | - H Cao
- Department of General Surgery, General Hospital of Oriental Hospital Group, Huainan, Anhui 232001, China
| | - S C Wang
- Department of General Surgery, the 901th Hospital of PLA Joint Logistic Support Force, Hefei, Anhui 230031, China
| | - G Han
- Department of Gastrointestinal Surgery, the Second Hospital of Jilin University, Changchun, Jilin 130000, China
| | - D R Wang
- Department of General Surgery, Subei People's Hospital, Yangzhou, Jiangsu 225001, China
| | - H Wang
- Department of General Surgery, Dongying People's Hospital, Dongying, Shandong 257091, China
| | - J Zhang
- Department of General Surgery, FAW General Hospital, Changchun, Jilin 100191, China
| | - H Zhang
- Department of General Surgery, Dongguan Kanghua Hospital, Dongguan, Guangdong 523080, China
| | - D M Zhang
- Department of General Surgery, Baotou Central Hospital, Baotou, Inmer Mongolia 014040, China
| | - W S Liao
- Department of General Surgery, Traditional Chinese Medicine Hospital of Langxi County, Xuancheng, Anhui 242000, China
| | - W W Zhao
- Department of General Surgery, Xishan People's Hospital, Wuxi, Jiangsu 214100, China
| | - W Li
- Department of General Surgery, Xuzhou First People's Hospital, Xuzhou, Jiangsu 221002, China
| | - P Cui
- Department of General Surgery, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 140400, China
| | - X Chen
- Department of General Surgery, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China
| | - H Y Zhang
- Department of General Surgery, Nanyang Central Hospital, Nanyang, Henan 476000, China
| | - T Yang
- Department of General Surgery, Tianjin First Central Hospital, Tianjin 300192, China
| | - L Wang
- Department of General Surgery, the 900th Hospital of the PLA, Fuzhou, Fujian 350000, China
| | - Y S Gao
- Department of Gastrointestinal Surgery,the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
| | - J Li
- Department of Hepatobiliary Surgery, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China
| | - J J Wu
- Department of General Surgery, Liyang People's Hospital, Liyang, Jiangsu 213300, China
| | - W Zhou
- Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310020, China
| | - Z J Lyu
- Department of Gastrointestinal Surgery, Guangdong Provincial People's Hospital, Guangzhou, Guangdong 510030, China
| | - J Fang
- Department of General Surgery, the First People's Hospital, Zhangjiagang, Jiangsu 100191, China
| |
Collapse
|
23
|
Xu P, Ze LJ, Kang WN, Wu JJ, Jin L, Anjum AA, Li GQ. Functional divergence of white genes in Henosepilachna vigintioctopunctata revealed by RNA interference. Insect Mol Biol 2020; 29:466-476. [PMID: 32654258 DOI: 10.1111/imb.12656] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2019] [Revised: 06/06/2020] [Accepted: 06/15/2020] [Indexed: 06/11/2023]
Abstract
Henosepilachna vigintioctopunctata is a serious pest of Solanaceae and Cucurbitaceae in many Asian countries. RNA interference (RNAi) can effectively reduce transcript abundance in this beetle, offering opportunities to explore the biological function of specific genes. The white gene encodes a half-type ATP-binding cassette transporter that plays an essential role in tryptophan, guanine and uric acid transport across membranes. Mutations that disrupt the function of white are known to cause eye pigmentation phenotypes in many insect species. Here, we found evidence for five white gene paralogues present in H. vigintioctopunctata transcriptome datasets sequenced from a range of developmental stages. We individually knocked down each of the five white genes through the injection of corresponding double-stranded RNAs (dsRNAs) to the fourth-instar larvae to determine whether functional divergence has occurred. We found that injecting 1 μg dswhite3 caused compound eye colour of pupae and adults to develop as red/brown and brown, respectively, compared with black eyes in control beetles. Injection of 2 μg dswhite3 increased RNAi efficacy and produced a clearer eye colour phenotype. At both doses, the ocular diaphragm (a ring of black pigment surrounding each eye) did not change in the white3 RNAi hypomorphs. Moreover, our data revealed that injection of dswhite2 at the fourth-instar larval stage impaired the climbing ability of both male and female adults. Our results confirmed, for the first time, functional divergence of duplicated white genes in an insect species.
Collapse
Affiliation(s)
- P Xu
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, China
| | - L-J Ze
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, China
| | - W-N Kang
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, China
| | - J-J Wu
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, China
| | - L Jin
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, China
| | - A A Anjum
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, China
| | - G-Q Li
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, China
| |
Collapse
|
24
|
Ghamrawi RI, Ghiam N, Wu JJ. Comparison of psoriasis guidelines for use of IL-23 inhibitors in the United States and United Kingdom: a critical appraisal and comprehensive review. J DERMATOL TREAT 2020; 33:1252-1256. [PMID: 32962478 DOI: 10.1080/09546634.2020.1826394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
PURPOSE This review article aims to compare global dermatologic organizations and the clinical practice guidelines available for the use of interleukin (IL)-23 inhibitors in the treatment of psoriasis. MATERIALS AND METHODS A literature review encompassing systemic therapies for the treatment of psoriasis was conducted. Guidelines from the American Academy of Dermatology (AAD)-National Psoriasis Foundation (NPF), the National Institute for Health and Care Excellence (NICE), and the British Association of Dermatologists (BAD) served as the main comparators in this review. RESULTS Of the American and European guidelines available for use of IL-23 inhibitors, several organizations are in agreement regarding the dosage and indications of guselkumab, tildrakizumab, and risankizumab. However, there are differences as well as insufficient recommendations concerning laboratory monitoring and screenings as well as contraindications to therapy. CONCLUSION IL-23 inhibitors are safe and efficacious therapeutic options for patients with psoriasis and should be considered as a potential first-line therapy alone or in combination with topical medications, phototherapy, and other systemic non-biologic agents. Consideration should be given to the evidence-based guidelines of global dermatologic organizations to help guide therapeutic decisions.
Collapse
Affiliation(s)
- R I Ghamrawi
- Edward Via College of Osteopathic Medicine, Auburn, AL, USA
| | - N Ghiam
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| |
Collapse
|
25
|
Lan P, Wu JJ, He Z. [Novel insight into the role of gut microbiome in colorectal surgery]. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23:21-26. [PMID: 32594721 DOI: 10.3760/cma.j.cn.441530-20200519-00287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Colorectal surgery is a major therapeutic approach for various colorectal diseases. Surgery and perioperative management, such as fasting, mechanical bowel preparation, and antibiotics use, have an impact on the composition and function of gut microbiome. Abnormal microbiome reconstruction may lead to multiple complications, including infection, gastrointestinal dysfunction, anastomotic leak and disease recurrence. The aim of this review is to elucidate the roles and mechanisms of perioperative interventions of colorectal surgery on gut microbiome, which may provide a novel insight into the microbe-based therapies in the perioperative period of colorectal surgery.
Collapse
Affiliation(s)
- P Lan
- Department of Colorectal Surgery, the Six Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China
| | - J J Wu
- Department of Colorectal Surgery, the Six Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China
| | - Z He
- Department of Colorectal Surgery, the Six Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China
| |
Collapse
|
26
|
Deng C, Ren BY, Huang XP, Tan JJ, Wu JJ, Wang W, Zhu C. Role of lymphocyte subsets and IL-17 in non-small cell lung cancer. J BIOL REG HOMEOS AG 2020; 34:319-326. [PMID: 32431141 DOI: 10.23812/19-449-16-l] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- C Deng
- Department of Oncology, Chongqing Three Gorges Central Hospital, Wanzhou District, Chongqing, China
| | - B Y Ren
- Department of Oncology, Chongqing Three Gorges Central Hospital, Wanzhou District, Chongqing, China
| | - X P Huang
- Department of Oncology, Chongqing Three Gorges Central Hospital, Wanzhou District, Chongqing, China
| | - J J Tan
- Department of Oncology, Chongqing Three Gorges Central Hospital, Wanzhou District, Chongqing, China
| | - J J Wu
- Department of Oncology, Chongqing Three Gorges Central Hospital, Wanzhou District, Chongqing, China
| | - W Wang
- Department of Oncology, Chongqing Three Gorges Central Hospital, Wanzhou District, Chongqing, China
| | - C Zhu
- Department of Oncology, Chongqing Three Gorges Central Hospital, Wanzhou District, Chongqing, China
| |
Collapse
|
27
|
Huang P, Wang CH, Zhuo LY, Xia XS, Yang S, Zhang JW, Fan HZ, Wu JJ, Yu R, Yue M, Zhang Y. Polymorphisms rs763110 in FASL is linked to hepatitis C virus infection among high-risk populations. Br J Biomed Sci 2020; 77:112-117. [PMID: PMID: 32209020 DOI: 10.1080/09674845.2020.1747182] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
BACKGROUND The Fas cell surface death receptor (FAS) and Fas ligand (FASL) can participate in the apoptosis of immune cells and target cells infected with a virus through the FAS-FASL signalling pathway. The decoy receptor 3 (DCR3) can competitively inhibit the binding of FAS to FASL. Our aim is to investigate the effect of single nucleotide polymorphisms (SNPs) in FAS, FASL and DCR3 on hepatitis C virus (HCV) infection. METHODS Four SNPs (rs763110 in FASL, rs1324551 and rs2234767 in FAS and rs2257440 in DCR3) were genotyped in 1495 controls free of HCV, 522 individuals with spontaneous HCV clearance and 732 patients with hepatitis C virus infection. The RegulomeDB database and RNAfold web servers were used to explore potential biological functions of SNPs. RESULTS FASL rs763110 was associated with susceptibility to HCV infection, and not to CHC. The odds ratio (95% confidence interval) of HCV infection in high-risk populations carrying FASL rs763110-TT was 1.82 (1.36-2.51, P < 0.001) compared to that of CC genotypes and 1.93 (1.43-2.60, P < 0.001) higher than that of CC + CT genotypes. Based on computer simulation, FASL rs763110-T may affect the transcription of mRNA by affecting the binding of a transcription factor, leading to structural changes in mRNA. CONCLUSION The genetic variant in FASL is linked with HCV infection, but not to spontaneous HCV clearance.
Collapse
Affiliation(s)
- P Huang
- Department of Epidemiology and Biostatistics, Key Laboratory of Infectious Diseases, Nanjing Medical University , Nanjing, China.,Institute of Epidemiology and Microbiology, Eastern Theater Command Centers for Disease Control and Prevention , Nanjing, China
| | - C H Wang
- Institute of Epidemiology and Microbiology, Eastern Theater Command Centers for Disease Control and Prevention , Nanjing, China
| | - L Y Zhuo
- Department of Epidemiology and Biostatistics, Key Laboratory of Infectious Diseases, Nanjing Medical University , Nanjing, China
| | - X S Xia
- College of Life Science and Technology, Kunming University of Science and Technology , Kunming, China
| | - S Yang
- Department of Biostatistics, School of Public Health, Nanjing Medical University , Nanjing, China
| | - J W Zhang
- Department of Anesthesiology, Affiliated Drum-Tower Hospital of Medical College of Nanjing University , Jiangsu, China
| | - H Z Fan
- Department of Information, The First Affiliated Hospital of Nanjing Medical University , Nanjing, China
| | - J J Wu
- Department of Epidemiology and Biostatistics, Key Laboratory of Infectious Diseases, Nanjing Medical University , Nanjing, China
| | - R Yu
- Department of Epidemiology and Biostatistics, Key Laboratory of Infectious Diseases, Nanjing Medical University , Nanjing, China
| | - M Yue
- Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University , Nanjing, China.,State Key Laboratory of Virology, School of Basic Medical Sciences, Wuhan University , Wuhan, China
| | - Y Zhang
- Department of Epidemiology and Biostatistics, Key Laboratory of Infectious Diseases, Nanjing Medical University , Nanjing, China.,Institute of Epidemiology and Microbiology, Eastern Theater Command Centers for Disease Control and Prevention , Nanjing, China
| |
Collapse
|
28
|
Wu JJ, Lin CY, Goldblum O, Zbrozek A, Comer BS, Burge R, Augustin M, Feldman SR. Efficacious psoriasis treatment improves patients' work productivity. J Eur Acad Dermatol Venereol 2020; 34:e593-e596. [PMID: 32277526 DOI: 10.1111/jdv.16457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| | - C-Y Lin
- Eli Lilly and Company, Indianapolis, IN, USA
| | - O Goldblum
- Eli Lilly and Company, Indianapolis, IN, USA
| | - A Zbrozek
- Eli Lilly and Company, Indianapolis, IN, USA
| | - B S Comer
- Eli Lilly and Company, Indianapolis, IN, USA
| | - R Burge
- Eli Lilly and Company, Indianapolis, IN, USA.,College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA
| | - M Augustin
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - S R Feldman
- Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA
| |
Collapse
|
29
|
Qu LF, Bai J, Jeffrey J, Jin J, Wu JJ. [Clinical application of three cases of transcarotid artery revascularization]. Zhonghua Yi Xue Za Zhi 2020; 100:978-982. [PMID: 32294853 DOI: 10.3760/cma.j.cn112137-20191120-02524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the surgical indications, preoperative evaluation, technical points, perioperative management and effect of transcarotid artery revascularization (TCAR) in the treatment of carotid stenosis. Methods: From March to April 2019, three patients with carotid stenosis undergoing TCAR in the Second Affiliated Hospital of Naval Military Medical University. With the common carotid artery approach, under the protection of the carotid-femoral vein reverse blood flow, the balloon dilatation of the internal carotid artery stenosis and stent implantation to achieve the purpose of carotid revascularization.The patient's general condition, preoperative evaluation, intraoperative operation, postoperative management and complications were recorded in detail. The clinical safety, efficacy and efficacy of TCAR in the treatment of carotid stenosis were evaluated. Results: All three operations were successful, including 2 cases of left carotid artery revascularization and 1 case of right carotid artery revascularization. A total of 3 carotid stents were implanted. The operation time was 65, 59, and 55 min,the intraluminal operation time was 13, 18, and 11 min, the common carotid artery blocked time was 15, 20, and 13 min, the contrast agent was 20, 25,15 ml, respectively. There was no death, no nervous system and other related complications during the perioperative period. Three patients were followed up for 7, 7, and 6 months without death, there were no nervous system diseases and other complications. All patients with ultrasound indicated that the carotid artery stent was patency. Conclusion: TCAR adopts the neuroprotection system of carotid-femoral vein continuous reverse blood flow to prevent transient ischemic attack (TIA) and stroke, and it is a safe and effective treatment for carotid artery stenosis.
Collapse
Affiliation(s)
- L F Qu
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - J Bai
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - J Jeffrey
- Department of Vascular Surgery, Washington University in St. Louis School of Medical, Missouri, St.Louis, 63101, USA
| | - J Jin
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - J J Wu
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| |
Collapse
|
30
|
Fowler E, Ghamrawi RI, Ghiam N, Liao W, Wu JJ. Risk of tuberculosis reactivation during interleukin-17 inhibitor therapy for psoriasis: a systematic review. J Eur Acad Dermatol Venereol 2020; 34:1449-1456. [PMID: 32012384 DOI: 10.1111/jdv.16254] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2019] [Accepted: 01/22/2020] [Indexed: 12/12/2022]
Abstract
Immunosuppressive therapies, effective in treating inflammatory disorders such as psoriasis, increase the risk of serious infections, such as tuberculosis (TB). For example, tumour necrosis factor (TNF)-alpha inhibitors significantly increase the risk of TB reactivation in patients with latent TB infection (LTBI), which has led clinicians to routinely test for TB prior to initiation of these medications. This protocol has since extended to other, newer immunomodulatory therapies for psoriasis, such as interleukin (IL)-17 inhibitors, including secukinumab, ixekizumab and brodalumab. We conducted a systematic review to examine whether there is any evidence that IL-17 inhibitor therapy for psoriasis increases the risk of TB reactivation. Using PubMed and EMBASE, our literature search resulted in 139 total articles. After manually reviewing each article for the discussion of IL-17 inhibitors for psoriasis, with data originating from clinical trials, and assessment for incidence of TB reactivation, 23 articles met the full inclusion criteria for our review. Overall, we found no cases of TB reactivation in patients treated with IL-17 inhibitors for psoriasis. This suggests that IL-17 inhibitors may be safely used in psoriasis patients with LTBI who receive appropriate LTBI treatment. However, long-term real-world studies are warranted to further evaluate this risk.
Collapse
Affiliation(s)
- E Fowler
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
| | - R I Ghamrawi
- Edward Via College of Osteopathic Medicine, Auburn, AL, USA
| | - N Ghiam
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
| | - W Liao
- Department of Dermatology, University of California San Francisco, San Francisco, CA, USA
| | - J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| |
Collapse
|
31
|
Hoegsberg T, Iversen L, Lange MM, Bissonette R, Carvalho AVE, van de Kerkhof PC, Kirby B, Kleyn CE, van der Walt JM, Wu JJ, Lynde CW. Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites. J DERMATOL TREAT 2020; 32:916-921. [PMID: 31996058 DOI: 10.1080/09546634.2020.1724250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Background: Currently, no formalized international consensus guidelines exist to direct optimal topical treatment including long-term treatment.Objective: In this survey, we aim to examine if and which topicals are used in clinical practice in long-term continuous treatment of psoriasis and how topicals are used in treating specific sites of the body.Methods: A questionnaire was distributed electronically to dermatologists from the International Psoriasis Council (IPC) representing 26 countries.Results: The top three topicals used across all severities of disease were topical corticosteroids, vitamin D analogs, and potent topical corticosteroids in combination with vitamin D analogs. On locations where the skin is thin, flexural and genital psoriasis, lower potency topical corticosteroids were used, whereas on other sites, in particular in palmoplantar psoriasis, superpotent topical corticosteroids and combination vitamin D analogs/corticosteroids were used.Conclusions: It is relevant to optimize localized therapy for all severities of psoriasis reconciling disease activity (stable vs. unstable disease), localization of the lesions and the individual patient and his/her perspectives on disease control. Topical therapies are valuable treatments for classical mild disease and may have a position in some patients with more severe manifestations.
Collapse
Affiliation(s)
- T Hoegsberg
- Department of Dermatology, Aarhus University Hospital, Aarhus C, Denmark
| | - L Iversen
- Department of Dermatology, Aarhus University Hospital, Aarhus C, Denmark
| | - M M Lange
- Department of Dermatology, Aarhus University Hospital, Aarhus C, Denmark
| | | | | | | | - B Kirby
- St. Vincents Hospital, Dublin, Ireland
| | - C E Kleyn
- The Dermatology Centre, Manchester Academic Health Science Centre, Salford Royal NHS, Foundation Trust, Manchester, UK
| | | | - J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, USA
| | - C W Lynde
- Department of Medicine, University of Toronto, Toronto, Canada
| |
Collapse
|
32
|
Li FH, Yu P, Song CH, Wu JJ, Tian Y, Wu XF, Zhang XW, Liu YM. Differential protein analysis of Heracleum moellendorffii Hance seeds during stratification. Plant Physiol Biochem 2019; 145:10-20. [PMID: 31665663 DOI: 10.1016/j.plaphy.2019.10.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/13/2019] [Revised: 09/16/2019] [Accepted: 10/01/2019] [Indexed: 06/10/2023]
Abstract
Heracleum moellendorffii Hance is a medicinal vegetable species, and the seed dormancy of this species has caused many agricultural problems. One stratification technique involves alternating layers of seeds and substrate to allow post-ripening of dormant seeds under appropriate environmental conditions and to release dormancy. Non-stratified seeds (NS), cotyledon-stage-embryo seeds (CS) and germinated seeds (GS) represent key stages of H. moellendorffii seeds during stratification. To better understand the breaking of dormancy caused by stratification, tandem mass tag (TMT) mass spectrometry (MS)/MS was used to detect proteins among NS, CS and GS. A total of 876 proteins were identified, which were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. The results showed that carbohydrate metabolic processes, responses to stress and ribosome biogenesis were the main biological processes. The changes in protein accumulation were validated by qRT-PCR. The results showed that starch, sucrose, pyruvate and fatty acid metabolism played significant roles and that the contents of stored substances were gradually degraded during stratification. This study provides a theoretical basis in terms of proteomics for exploring the post-ripening and germination of H. moellendorffii seeds.
Collapse
Affiliation(s)
- F H Li
- College of Life Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin, 150030, Heilongjiang, China.
| | - P Yu
- College of Life Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin, 150030, Heilongjiang, China
| | - C H Song
- College of Life Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin, 150030, Heilongjiang, China
| | - J J Wu
- College of Life Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin, 150030, Heilongjiang, China
| | - Y Tian
- College of Life Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin, 150030, Heilongjiang, China
| | - X F Wu
- College of Life Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin, 150030, Heilongjiang, China
| | - X W Zhang
- College of Life Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin, 150030, Heilongjiang, China
| | - Y M Liu
- College of Life Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin, 150030, Heilongjiang, China
| |
Collapse
|
33
|
Zhu P, Yue M, Chen Q, Yao M, Wu JJ, Shao JG, Xue H, Zhang Y, Huang P, Wang CH. [Study of tumor necrosis factor receptor superfamily 1B gene polymorphism in relation to the outcomes of HCV infection]. Zhonghua Gan Zang Bing Za Zhi 2019; 27:793-798. [PMID: 31734995 DOI: 10.3760/cma.j.issn.1007-3418.2019.10.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the tumor necrosis factor receptor superfamily 1B gene (TNFRSF1B) polymorphism in relation to the outcomes of hepatitis C virus (HCV) infection. Methods: One thousand six hundred and forty-five cases without HCV infection, 545 cases with HCV clearance, and 783 cases with chronic HCV infection were enrolled. TaqMan probe method was used to investigate genotype rs1061622 (T > G) and rs1061624 (G > A). Two single nucleotide polymorphisms (SNPs) sites were genotyped and haplotypes were constructed to evaluate their relation with the outcome of HCV infection. Results: Logistic regression analysis showed that there was no relation to the two SNPs with HCV infection susceptibility and chronicity (P > 0.05). Haplotype analysis showed that carrier TA had an increased susceptibility to HCV infection [adjusted odds ratio (OR) = 1.15, 95% confidence interval (CI): 1.01 to 1.30, P = 0.038)]. Carrier TA and GG haplotypes were conducive to chronic HCV infection (adjusted OR = 1.28, 95% CI: 1.08 to 1.53, P = 0.006; OR = 1.31, 95% CI: 1.03 to 1.66, P = 0.026). Conclusion: The combinational effects of rs1061622 and rs1061624 in TNFRSF1B gene may increase the risk of HCV chronicity and infection.
Collapse
Affiliation(s)
- P Zhu
- Medical Department, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - M Yue
- Department of Infectious Diseases, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - Q Chen
- Eastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China
| | - M Yao
- Department of Immunology, Medical School of Nantong University, Nantong 226001, China
| | - J J Wu
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - J G Shao
- Department of Gastroenterology, the Nantong Third Affiliated Hospital of Nantong University, Nantong 226001, China
| | - H Xue
- Fourth Ward, the Nantong Third Affiliated Hospital of Nantong University, Nantong 226001, China
| | - Y Zhang
- Eastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - P Huang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - C H Wang
- Eastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China
| |
Collapse
|
34
|
Wu JJ, Huang P, Yue M, Wang CH, Wu C, Shao JG, Xue H, Fu ZQ, Zhuo LY, Yu RB, Zhang Y. [Association between TNFRSF11A and TNFRSF11B gene polymorphisms and the outcome of hepatitis C virus infection]. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 40:1291-1295. [PMID: 31658533 DOI: 10.3760/cma.j.issn.0254-6450.2019.10.022] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the relationship between the tumor necrosis factor receptor superfamily members 11A (TNFRSF11A) and 11B (TNFRSF11B) gene polymorphisms and the outcome of hepatitis C virus (HCV) infection. Methods: In this case-control study, 749 cases of persistent HCV infection, 494 cases of spontaneous clearance and 1 486 control subjects were included from 2008 to 2016. TaqMan-MGB probe method was used to detect the genotype of TNFRSF11A rs1805034 and TNFRSF11B rs2073617. The genotypes distribution of the two single nucleotide polymorphisms (SNP) were analyzed in different populations. Results: Co-dominant model showed that individuals carrying the rs2073617 CC genotype were prone to have chronic HCV infection, compared with individuals carrying the rs2073617 TT genotype (OR=1.517, 95%CI: 1.055-2.181, P=0.024). Recessive model results showed that individuals carrying rs2073617 CC genotype were more likely to develop chronic HCV infection compared with individuals carrying rs2073617 TT or TC genotype (OR=1.435, 95%CI: 1.033-1.996, P=0.032). Additive model showed that the risk for chronic HCV infection increased with the increase of the number of rs2073617 C alleles (OR=1.204, 95%CI: 1.013-1.431, P=0.035). Conclusion: The genetic polymorphism of TNFRSF11B rs2073617 might be related with the chronicity of HCV infection.
Collapse
Affiliation(s)
- J J Wu
- Key Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - P Huang
- Key Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - M Yue
- Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - C H Wang
- Eastern Theater Command Center for Disease Prevention and Control, Nanjing 210002, China
| | - C Wu
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - J G Shao
- Department of Gastroenterology, The Third People's Hospital of Nantong Affiliated to Nantong University, Nantong 226001, China
| | - H Xue
- Fourth Ward, The Third People's Hospital of Nantong Affiliated to Nantong University, Nantong 226001, China
| | - Z Q Fu
- Key Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - L Y Zhuo
- Key Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - R B Yu
- Key Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - Y Zhang
- Key Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Eastern Theater Command Center for Disease Prevention and Control, Nanjing 210002, China
| |
Collapse
|
35
|
Zhuo LY, Huang P, Fan HZ, Wu JJ, Wang Y, Ye XY, Yu RB. [Study on thyroid hormone levels and influence factors in drug users in a drug rehabilitation center in Jiangsu province]. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 40:1134-1138. [PMID: 31594160 DOI: 10.3760/cma.j.issn.0254-6450.2019.09.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To understand the serum levels of thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), triiodothyronine (T3), and thyroxine (T4) and identify the related influencing factors of thyroid dysfunction in drug users. Methods: From June to August 2018, a face-to-face questionnaire survey was conducted in 788 male drug users in a drug rehabilitation center in Jiangsu province to collect their socio-demographic information. Then, venous blood sample was collected from each participant for the detection of various hematological indicators, such as thyroid hormones. Results: The abnormal rates of T3, T4, FT3, FT4 and TSH were 4.57%, 1.27%, 0.51%, 0.38% and 0.89%, respectively, in the male drug users. HCV infection was an influencing factor for abnormal T3 level in the male drug users (OR=8.52, 95%CI: 2.36-30.74, P=0.001). And serum T3 (P<0.001) and T4 (P=0.048) levels increased with increasing HCV viral load. Conclusions: HCV infection was an influencing factor for the abnormality of serum T3 level in drug users. Therefore, thyroid-related knowledge should be added in the health education for drug users, and the monitoring of thyroid function should be strengthened for drug users infected with HCV.
Collapse
Affiliation(s)
- L Y Zhuo
- School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | | | | | | | | | | | | |
Collapse
|
36
|
Deng HY, Wang X, Chen H, Wu JJ, Wang K, Jia Y, Liu C, Yin DJ, Liu YP. [Lung adenocarcinoma with epidermal growth factor receptor mutation transferred to the oral cavity: a report of two cases]. Zhonghua Kou Qiang Yi Xue Za Zhi 2019; 54:691-693. [PMID: 31607006 DOI: 10.3760/cma.j.issn.1002-0098.2019.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- H Y Deng
- Department of Pathology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| | - X Wang
- Department of Pathology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| | - H Chen
- Department of Stomatology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| | - J J Wu
- Department of Stomatology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| | - K Wang
- Department of Pathology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| | - Y Jia
- Department of Pathology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| | - C Liu
- Department of Pathology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| | - D J Yin
- Department of Pathology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| | - Y P Liu
- Department of Pathology, The Fourth Hospital of Hebei Medical Universiry & The Tumor Hospital of Hebei Province, Shijiazhuang 050011, China
| |
Collapse
|
37
|
Mai L, Luo M, Wu JJ, Yang JH, Hong LY. The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells. Neoplasma 2019; 66:776-784. [PMID: 31169018 DOI: 10.4149/neo_2018_180921n708] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2018] [Accepted: 04/28/2019] [Indexed: 11/08/2022]
Abstract
Hypoxia-inducible factor 1α (HIF1α) has been demonstrated to be involved in the resistance of various human cancer cells to chemotherapies. However, the correlation between HIF1α and the sensitivity of human non-small cell lung cancer (NSCLC) cells to cisplatin has not been illuminated. The aim of the present study was to investigate the effects of HIF1α on drug resistance in NSCLC cells. A549 cells were incubated in 21% or 0.5% O2 followed by the assessment of the level of HIF1α with qRT-PCR and western blot and ROS level by DCFH-DA assays. Effects of hypoxia or HIF1α inhibitor LW6 on the proliferation and apoptosis of A549 cells were evaluated via CCK-8 and flow cytometry assays. IC50 of A549 cells to cisplatin was determined by MTT assay. The mitochondrial membrane potential (MMP) was measured via JC-1 staining. Moreover, the expression of apoptosis related protein (Bcl-2, Bax) and drug resistance related proteins (MDR1, MRP1) were measured by western blotting. Exposure of A549 cells to 1% O2 significantly up-regulated HIF1α expression, maintained cell viability to cisplatin but decreased the ROS level, which promoted chemoresistance to cisplatin. LW6-treated A549 cells showed an increase in ROS level that blocked the hypoxia induced resistance to cisplatin and in addition, decreased expression of MDR1 and MRP1 in cisplatin-treated cells. This study revealed that hypoxia-improved cisplatin chemoresistance of NSCLC cells by regulated MDR1 and MRP1 expression via HIF1α/ROS pathway is reversed by LW6, suggesting that LW6 may act as effective sensitizer in chemotherapy for NSCLC.
Collapse
Affiliation(s)
- L Mai
- Department of Respiratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China
| | - M Luo
- Department of Respiratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China
| | - J J Wu
- Department of Respiratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China
| | - J H Yang
- Department of Respiratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China
| | - L Y Hong
- Department of Respiratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China
| |
Collapse
|
38
|
Lee EB, Wu JJ. Safety of long-term interleukin-23 inhibition in patients with psoriasis. Br J Dermatol 2019; 180:977-978. [PMID: 31025743 DOI: 10.1111/bjd.17784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- E B Lee
- University of Hawaii, John A. Burns School of Medicine, Honolulu, HI, U.S.A
| | - J J Wu
- Dermatology Research and Education Foundation, Irvine, CA, U.S.A
| |
Collapse
|
39
|
Wang H, Fu L, Lu HM, Kang XN, Wu JJ, Xu FJ, Yu TJ. Anisotropic dependence of light extraction behavior on propagation path in AlGaN-based deep-ultraviolet light-emitting diodes. Opt Express 2019; 27:A436-A444. [PMID: 31052894 DOI: 10.1364/oe.27.00a436] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2019] [Accepted: 03/05/2019] [Indexed: 06/09/2023]
Abstract
The anisotropic extraction dependence of polarized light on propagation path in AlGaN-based deep-ultraviolet (DUV) light-emitting diodes (LEDs) is investigated by simulations and photoluminescence (PL) measurements. Theoretical calculations based on k⋅p approximation and Monte Carol ray tracing indicate that there are two kinds of polarized sources with different angular distributions in ~280 nm AlGaN-based LEDs, s-polarized (spherical-shaped) and p-polarized (dumbbell-shaped) sources, which have different extraction behaviors. It is found that the total light extraction intensities are improved with decreasing the propagation path, and the lateral surface extraction gradually becomes dominant. Moreover, the extraction intensity of s-polarized light improves more than that of p-polarized light when the propagation path decreases, leading to a greater polarization degree. Polarization-resolved PL measurements show that the polarization degree of extracted light from lateral facet of the AlGaN multiple quantum well sample can be enhanced from 1% to 17% as the average propagation path reduces by 0.6 mm, which is consistent with the simulation results of the anisotropic dependence of light extraction on propagation path. Our results are significant for understanding and modulating the anisotropic extraction behavior of polarized light to realize high efficiency AlGaN-based DUV LEDs.
Collapse
|
40
|
Ren GH, Yan QJ, Tang Y, Wu JJ, Zhang JH, Song JW, Liu NG. Research Progress on Detection Methods of Amphetamines in Human Hair. Fa Yi Xue Za Zhi 2019; 35:89-94. [PMID: 30896127 DOI: 10.12116/j.issn.1004-5619.2019.01.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 10/16/2017] [Indexed: 11/30/2022]
Abstract
Amphetamines are chemical synthetic drugs that are becoming increasingly popular in China. As a common sample in the inspection of poisons, hair has the advantages of easy storage, good stability, and long detection time compared with traditional human body fluid samples (blood, urine), thus possesses an unique application value in the field of forensic toxicology analysis. By now, methods for detecting amphetamines in human hair have been widely used, and validity of the results has been recognized and adopted by the court. This paper reviews domestic and foreign research progress of the detection of amphetamines in hair samples, including the pretreatment and analytic methods.
Collapse
Affiliation(s)
- G H Ren
- Guangdong Kingmed Forensic Institute, Guangzhou 510220, China
| | - Q J Yan
- Guangdong Kingmed Forensic Institute, Guangzhou 510220, China
| | - Y Tang
- Guangdong Kingmed Forensic Institute, Guangzhou 510220, China
| | - J J Wu
- Guangdong Kingmed Forensic Institute, Guangzhou 510220, China
| | - J H Zhang
- Guangdong Kingmed Forensic Institute, Guangzhou 510220, China
| | - J W Song
- Guangdong Justice Police Vocational College, Guangzhou 510430, China
| | - N G Liu
- Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China
| |
Collapse
|
41
|
Liang SL, Wei ZH, Wu JJ, Dong XL, Liu JX, Wang DM. Effect of N-acetyl-l-methionine supplementation on lactation performance and plasma variables in mid-lactating dairy cows. J Dairy Sci 2019; 102:5182-5190. [PMID: 30904299 DOI: 10.3168/jds.2018-15716] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Accepted: 01/29/2019] [Indexed: 01/06/2023]
Abstract
The objective of current study was to investigate the effect of N-acetyl-l-methionine (NALM) supplementation on lactation performance and plasma variables in mid-lactating dairy cows. Forty-eight multiparous cows were blocked into 12 groups based on parity, days in milk, and milk production and were randomly assigned to 1 of the 4 treatments: 0, 15, 30, or 60 g/d of NALM per cow to supplement the basal diet. The experiment was conducted over a 13-wk period, with the first week as adaptation. The yields of milk, fat-corrected milk, and milk lactose were increased quadratically, and energy-corrected milk yield tended to increase with increased NALM supplementation in a quadratic manner. The dry matter intake, milk protein yield, milk fat yield, contents of milk composition (protein, fat, lactose, total solids, and milk urea nitrogen), feed efficiency, and body weight change were not affected by NALM supplementation. In addition, plasma methionine concentration was increased quadratically, and proline, total nonessential AA, and total AA concentrations were significantly higher in the 30 g/d group compared with that of the control group. However, other AA and total essential AA concentrations were not affected with supplementation of NALM. Adding NALM increased concentrations of total protein and globulin in plasma, but decreased plasma urea nitrogen concentration in a quadratic manner. Meanwhile, plasma malonaldehyde concentration decreased linearly as doses of NALM addition increased. Our results suggested that the supplementation of NALM improved milk yield and protein synthesis in the liver, and lowered lipid peroxidation in mid-lactating dairy cows.
Collapse
Affiliation(s)
- S L Liang
- Institute of Dairy Science, MoE Key Laboratory of Molecular Animal Nutrition, College of Animal Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - Z H Wei
- Institute of Dairy Science, MoE Key Laboratory of Molecular Animal Nutrition, College of Animal Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - J J Wu
- Institute of Dairy Science, MoE Key Laboratory of Molecular Animal Nutrition, College of Animal Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - X L Dong
- CJ International Trading Co. Ltd., Shanghai 200050, P.R. China
| | - J X Liu
- Institute of Dairy Science, MoE Key Laboratory of Molecular Animal Nutrition, College of Animal Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - D M Wang
- Institute of Dairy Science, MoE Key Laboratory of Molecular Animal Nutrition, College of Animal Sciences, Zhejiang University, Hangzhou 310058, P.R. China.
| |
Collapse
|
42
|
Wu JJ, Chen ZC, Wang YW, Fu KY, Guo WC, Li GQ. Silencing chitin deacetylase 2 impairs larval-pupal and pupal-adult molts in Leptinotarsa decemlineata. Insect Mol Biol 2019; 28:52-64. [PMID: 30058750 DOI: 10.1111/imb.12524] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Insect chitin deacetylases (CDAs) are carbohydrate esterases that catalyze N-deacetylation of chitin to generate chitosan, a process essential for chitin organization and compactness during the formation of extracellular chitinous structure. Here we identified two CDA2 splice variants (LdCDA2a and LdCDA2b) in Leptinotarsa decemlineata. Both splices were abundantly expressed in larval foregut, rectum, and epidermis; their levels peaked immediately before ecdysis within each instar. In vivo results revealed that the two isoforms transcriptionally responded, positively and negatively respectively, to 20-hydroxyecdysone and juvenile hormone signaling pathways. RNA interference (RNAi)-aided knockdown of the two LdCDA2 variants (hereafter LdCDA2) or LdCDA2b, rather than LdCDA2a, resulted in three negative effects. First, foliage consumption was significantly reduced, larval developing period was lengthened, and larval growth was retarded. Second, chitin contents were reduced, whereas glucose, trehalose, and glycogen contents were increased in the LdCDA2 and LdCDA2b RNAi larvae. Third, approximately 20% of LdCDA2 and LdCDA2b RNAi larvae were trapped within the exuviae and finally died. About 60% of the abnormal pupae died as pharate adults. Around 20% of the RNAi pupae emerged as deformed adults, with small size and wrinkled wings. These adults eventually died within 1 week after molting. Our results reveal that knockdown of CDA2 affects chitin accumulation. Consequently, LdCDA2 may be a potential target for control of L. decemlineata larvae.
Collapse
Affiliation(s)
- J-J Wu
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, China
| | - Z-C Chen
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, China
| | - Y-W Wang
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, China
| | - K-Y Fu
- Department of Plant Protection, Xinjiang Academy of Agricultural Sciences, Urumqi, 830091, China
| | - W-C Guo
- Department of Plant Protection, Xinjiang Academy of Agricultural Sciences, Urumqi, 830091, China
- Xinjiang Laboratory of Special Environmental Microbiology, Institute of Microbiology, Xinjiang Academy of Agricultural Sciences, Urumqi, 830091, China
| | - G-Q Li
- Education Ministry Key Laboratory of Integrated Management of Crop Diseases and Pests, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, China
| |
Collapse
|
43
|
Qu LF, Wu JJ. [A new classification of intra/extra cranial tandem carotid lesions and guidance to revascularisation selections]. Zhonghua Yi Xue Za Zhi 2019; 99:241-246. [PMID: 30669706 DOI: 10.3760/cma.j.issn.0376-2491.2019.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- L F Qu
- Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Military Medical University, Shanghai 200003, China
| | | |
Collapse
|
44
|
Qiao YM, Liang X, Lu YK, Zhuo LB, Wu JJ, Wang HX, Yao W, Yan Z. [The role of heme oxygenase-1 on oxidative stress injury induced by zinc oxide nanoparticles in human umbilical vein endothelial cells line EA.hy926 cells]. Zhonghua Yu Fang Yi Xue Za Zhi 2018; 52:1177-1181. [PMID: 30419705 DOI: 10.3760/cma.j.issn.0253-9624.2018.11.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the effect of heme oxygenase-1 (HO-1) on level of reactive oxygen species (ROS) induced by zinc oxide nanoparticles (ZnO-NPs) in Human umbilical vein endothelial cells line EA.hy926. Methods: The EA.hy926 cells in logarithmic growth phase were incubated with 0.0, 2.5, 5.0, 10.0 and 15.0 mg/L ZnO-NPs respectively. The ROS level, reflected by mean fluorescence intensity (MFI), was examined by flow cytometer after 4 hours exposure, the protein expression of HO-1 which was determined by Western Blot after exposed to ZnO-NPs for 24 hours. Cells incubated with 15.0 mg/L were set as the ZnO-NPs group; a blank control group was set at the same time. Cells were pretreated with HO-1 inhibitor zinc protoporphyrin (ZnPPIx) and HO-1 activator cobalt protoporphyrin (CoPPIx), they were classified as ZnPPIx group and CoPPIx group. 15 mg/L ZnO-NPs was chosen to conduct the experiment of HO-1 activation and inhibition. Cells were classified as ZnPPIX+ ZnO-NPs group and CoPPIx+ ZnO-NPs group after pretreated with 10 μmol/L ZnPPIx or CoPPIx for 1 h, added 15 mg/L ZnO-NPs to cell culture medium. In all groups ROS levels were detected after exposed to ZnO-NPs for 4 hours, the protein expression of HO-1 was detected after exposed to ZnO-NPs for 24 hours. Results: With the increased dose of ZnO-NPs, levels of ROS and HO-1 in EA.hy926 cells were clearly elevated (the MFI of 0.0, 2.5, 5.0, 10.0 and 15.0 mg/L ZnO-NPs incubated groups was 22 627.22±718.27, 24 726.47±568.52, 31 141.75±1 312.24, 39 824.82±4 774.74, 50 569.03±1 497.63 respectively, and HO-1 relative expression were 0.16±0.01, 0.19±0.02, 0.16±0.01, 0.23±0.02, 0.92±0.06 respectively). HO-1 expression in ZnPPIx pretreatment group decreased compared with ZnO-NPs group (1.05±0.05 vs. 1.12±0.01, P<0.05), meanwhile ROS level enhanced (62 683.95±2 589.59 vs. 53 654.53±2 229.01, P<0.05). However, CoPPIx pretreatment had higher HO-1 level and lower level of ROS compared with ZnO-NPs group (HO-1: 1.74±0.11 vs. 0.22±0.03, P<0.05; ROS: 32 845.04±993.48 vs. 53 654.53±2 229.01, P<0.05). Conclusions: Exposure to ZnO-NPs significantly induced ROS generation in EA.hy926 cells in a dose-dependent manner. HO-1 regulated ZnO-NPs-induced oxidative stress.
Collapse
Affiliation(s)
- Y M Qiao
- Department of Occupational and Environmental Health Sciences, School of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, China
| | | | | | | | | | | | | | | |
Collapse
|
45
|
Wan MT, Alvarez J, Shin DB, Dommasch ED, Wu JJ, Gelfand JM. Head-to-head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences. J Eur Acad Dermatol Venereol 2018; 33:42-55. [PMID: 29989662 DOI: 10.1111/jdv.15174] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2018] [Accepted: 06/28/2018] [Indexed: 11/26/2022]
Abstract
There is increasing use of head-to-head clinical trials in dermatology when establishing the efficacy of a new treatment. Active comparator trials (ACTs) can be classified into three distinct study trial designs: non-inferiority, equivalence and superiority. A better understanding of the statistical parameters, such as acceptable treatment differences (also known as the margin or delta), is necessary to properly design and interpret findings of active comparator trials (ACTs) in the field of dermatology. Therefore, the objective of this study was to summarize the maximum acceptable treatment differences in clinical trials that examine the efficacy of an oral or biologic psoriasis therapy with an active comparator. We conducted a systematic search using MEDLINE, Scopus, EMBASE, Cochrane Central Register of Controlled Trials, LILACS, Web of Science and ClinicalTrials.gov from inception to 31 August 2017. All ACTs with adult participants that had a primary outcome of the Psoriasis Area and Severity Index score were included. Bibliographies of articles were further reviewed. Two investigators independently assessed for article inclusion and separately completed data extraction of predefined data points. When there was a disagreement, a third investigator was consulted. Of the 49 ACTs included, there were 13 superiority, eight non-inferiority and seven equivalence trials. Another 21 studies had inadequate information for classification. All of the non-inferiority trials reported the margin, one of the superiority and six of the equivalence trials stated the treatment difference explicitly. For superiority trials, acceptable treatment differences ranged from 14% to 20%. The non-inferiority studies reported lower bound margins ranging from -20% to -10%. The equivalence trials reported upper and lower bound margins ranging from ±12.5% to ±18%. The results demonstrate the need for harmonization in the conduct of dermatological clinical trials and in the approaches of reporting research parameters.
Collapse
Affiliation(s)
- M T Wan
- Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| | - J Alvarez
- Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| | - D B Shin
- Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| | - E D Dommasch
- Department of Dermatology and Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
| | - J J Wu
- Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA
| | - J M Gelfand
- Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.,Department of Biostatistics Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| |
Collapse
|
46
|
Wu JJ, Lin C, Sun L, Goldblum O, Zbrozek A, Burge R, Augustin M, Feldman SR. Minimal clinically important difference (MCID) for work productivity and activity impairment (WPAI) questionnaire in psoriasis patients. J Eur Acad Dermatol Venereol 2018; 33:318-324. [PMID: 29846976 DOI: 10.1111/jdv.15098] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2018] [Accepted: 05/16/2018] [Indexed: 11/30/2022]
Abstract
BACKGROUND The clinical meaningfulness of improvements in the Work Productivity and Activity Impairment Questionnaire for Psoriasis (WPAI-PsO) reported by patients with psoriasis in response to treatment is unknown due to the lack of any publications that report minimal clinically importance differences (MCID) for WPAI-PsO outcomes. OBJECTIVE To determine the MCIDs for the work productivity loss and activity impairment domains of the Work Productivity and Activity Impairment Questionnaire for Psoriasis (WPAI-PsO) using results from three Phase 3 trials of ixekizumab. METHODS MCIDs for WPAI-PsO domains were derived using treatment agnostic data from patients participating in UNCOVER-1/-2/-3. The analysis included patients randomized to placebo and two ixekizumab treatment groups (ixekizumab either every 2 weeks or 4 weeks) from the trials. WPAI-PsO was administered at baseline and Week 12 for UNCOVER-1/-2/-3 and at Weeks 24, 36, 52 and 60 in UNCOVER-1/-2. MCIDs for the WPAI-PsO domains through Week 12 were derived using an anchor-based method supplemented with the distribution-based method. Anchors included 75%/90%/100% improvement in Psoriasis Area and Severity Index, Static Physicians Global Assessment (sPGA[0] and sPGA[0,1]) and Dermatology Life Quality Index MCID). MCIDs were triangulated using receiver operating characteristics (ROC) and distribution-based methods. RESULTS The analyses included 3126 patients (Placebo: 792, Ixekizumab: 2334). All anchors were shown to be valid. Significant differences in the domains of WPAI-PsO were observed between patients achieving clinically meaningful improvement in the validated anchors (all P-values < 0.001). ROC analyses suggested a 20% improvement in the work productivity loss or activity impairment components best represented the benefit of meeting a clinical meaningful improvement in the validated anchors. The distribution-based method supported the results of the anchor-based method. CONCLUSION The MCIDs for both the work productivity loss and the activity impairment domains of WPAI-PsO were estimated to be 20% in patients with PsO.
Collapse
Affiliation(s)
- J J Wu
- Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA
| | - C Lin
- Eli Lilly and Company, Indianapolis, IN, USA
| | - L Sun
- Eli Lilly and Company, Indianapolis, IN, USA
| | - O Goldblum
- Eli Lilly and Company, Indianapolis, IN, USA
| | - A Zbrozek
- Eli Lilly and Company, Indianapolis, IN, USA
| | - R Burge
- Eli Lilly and Company, Indianapolis, IN, USA.,College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA
| | - M Augustin
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - S R Feldman
- Department of Dermatology, Wake Forest University, Winston-Salem, NC, USA
| |
Collapse
|
47
|
Wu JJ, Joshi AA, Reddy SP, Batech M, Egeberg A, Ahlehoff O, Mehta NN. Anti-inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis. J Eur Acad Dermatol Venereol 2018; 32:1320-1326. [PMID: 29573294 DOI: 10.1111/jdv.14951] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Accepted: 02/09/2018] [Indexed: 01/05/2023]
Abstract
BACKGROUND Psoriasis is a systemic chronic inflammatory condition associated with increased risk of cardiovascular disease. Data demonstrating that decreased skin inflammation reduces cardiovascular events in patients with psoriasis may be generalizable to other chronic inflammatory states with heightened cardiovascular risk. OBJECTIVE To determine whether tumour necrosis factor inhibitor (TNFi) therapy is associated with decreased major adverse cardiovascular events (MACE) in patients with psoriasis. METHODS In this retrospective cohort study using the KPSC health plan, patients had at least three ICD-9 codes for psoriasis and no antecedent MACE codes. Propensity score-adjusted multivariable Cox regression assessed hazard ratios (HR) of MACE associated with TNFi use. RESULTS After adjusting for cardiovascular risk factors, the TNFi cohort had significantly lower MACE HR compared with the topical cohort (HR, 0.80; 95% CI, 0.66-0.98). The oral/phototherapy cohort had similar MACE HR compared with the topical cohort (HR, 1.19 (95% CI, 0.99-1.42)). CONCLUSIONS We observed significantly lower MACE risk in patients with psoriasis receiving TNFi compared to topical or oral/phototherapy agents. TNFi therapy may have benefits beyond skin disease in mitigating cardiovascular event risk.
Collapse
Affiliation(s)
- J J Wu
- Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA
| | - A A Joshi
- National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA
| | - S P Reddy
- University of Illinois at Chicago College of Medicine, Chicago, IL, USA
| | - M Batech
- Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA
| | - A Egeberg
- Department of Cardiology, The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.,Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark
| | - O Ahlehoff
- Department of Cardiology, Odense University Hospital, Odense, Denmark
| | - N N Mehta
- National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA
| |
Collapse
|
48
|
Wu JJ, Zheng J, Liu HP, Qiu MS, Liu WC, Lin Q. [The application of dermal fat flap in the reconstruction of deformity after resecting the nasal tip schwannoma: a case report]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018; 53:296-298. [PMID: 29747256 DOI: 10.3760/cma.j.issn.1673-0860.2018.04.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- J J Wu
- Department of Plastic and Reconstructive Surgery, First Hospital of Jilin University, Changchun 130021, China
| | - J Zheng
- Department of Plastic and Reconstructive Surgery, First Hospital of Jilin University, Changchun 130021, China
| | - H P Liu
- Department of Plastic and Reconstructive Surgery, First Hospital of Jilin University, Changchun 130021, China
| | - M S Qiu
- Department of Plastic and Reconstructive Surgery, First Hospital of Jilin University, Changchun 130021, China
| | - W C Liu
- Department of Plastic and Reconstructive Surgery, First Hospital of Jilin University, Changchun 130021, China
| | - Q Lin
- Department of Plastic and Reconstructive Surgery, First Hospital of Jilin University, Changchun 130021, China
| |
Collapse
|
49
|
Warren RB, Brnabic A, Saure D, Langley RG, See K, Wu JJ, Schacht A, Mallbris L, Nast A. Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab. Br J Dermatol 2018; 178:1064-1071. [PMID: 29171861 DOI: 10.1111/bjd.16140] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/14/2017] [Indexed: 12/24/2022]
Abstract
BACKGROUND Head-to-head randomized studies comparing ixekizumab and secukinumab in the treatment of psoriasis are not available. OBJECTIVES To assess efficacy and quality of life using matching-adjusted indirect comparisons for treatment with ixekizumab vs. secukinumab. METHODS Psoriasis Area and Severity Index (PASI) improvement of at least 75%, 90% and 100% and Dermatology Life Quality Index (DLQI) 0/1 response rates for approved dosages of ixekizumab (160 mg at Week 0, then 80 mg every two weeks for the first 12 weeks) and secukinumab (300 mg at Weeks 0, 1, 2, 3 and 4, then 300 mg every 4 weeks) treatment were compared using data from active (etanercept and ustekinumab) and placebo-controlled studies. Comparisons were made using the Bucher (BU) method and two modified versions of the Signorovitch (SG) method (SG total and SG separate). Subsequently, results based on active treatment common comparators were combined using generic inverse-variance meta-analysis. RESULTS In the meta-analysis of studies with active comparators, PASI 90 response rates were 12·7% [95% confidence interval (CI) 5·5-19·8, P = 0·0005], 10·0% (95% CI 2·1-18·0, P = 0·01) and 11·2% (95% CI 3·2-19·1, P = 0·006) higher and PASI 100 response rates were 11·7% (95% CI 5·9-17·5, P < 0·001), 12·7% (95% CI 6·0-19·4, P < 0·001) and 13·1% (95% CI 6·3-19·9, P < 0·001) higher for ixekizumab compared with secukinumab using BU, SG total and SG separate methods. PASI 75 results were comparable when SG methods were used and favoured ixekizumab when the BU method was used. Week 12 DLQI 0/1 response rates did not differ significantly. CONCLUSIONS Ixekizumab had higher PASI 90 and PASI 100 responses at week 12 compared with secukinumab using adjusted indirect comparisons.
Collapse
Affiliation(s)
- R B Warren
- Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, U.K
| | - A Brnabic
- Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A
| | - D Saure
- Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A
| | - R G Langley
- Division of Clinical Dermatology and Cutaneous Science, Dalhousie University, Halifax, NS, Canada
| | - K See
- Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A
| | - J J Wu
- Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, U.S.A
| | - A Schacht
- Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A
| | - L Mallbris
- Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A
| | - A Nast
- Division of Evidence-Based Medicine, Department of Dermatology, Venereology and Allergology, Charité Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
50
|
Lee EB, Thomas LW, Egeberg A, Wu JJ. Dosage adjustments in patients with psoriasis on adalimumab - a retrospective chart review. J Eur Acad Dermatol Venereol 2018; 32:e292-e293. [PMID: 29377299 DOI: 10.1111/jdv.14826] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- E B Lee
- John A Burns School of Medicine, University of Hawaii, 651 Ilalo St, Honolulu, HI, USA
| | - L W Thomas
- School of Medicine, University of California, Irvine, 1001 Health Sciences Rd, Irvine, CA, USA
| | - A Egeberg
- Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark
| | - J J Wu
- Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, 1515 North Vermont Ave, 5th floor, Los Angeles, CA, USA
| |
Collapse
|